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Scottish Parliament 
Health and Sport Committee 
Tuesday 3 October 2017 
[The Convener opened the meeting at 10:00] 
European Union Reporters 
The Convener (Neil Findlay): Good morning 
and welcome to the 22nd meeting in 2017 of the 
Health and Sport Committee. I ask everyone to 
ensure that their mobile phones are on silent. You 
can use your mobile phones for social media, but 
please do not take photographs or record 
proceedings.  
We have received apologies from Jenny Gilruth 
and Miles Briggs.  
The first item is the selection of two new 
European Union rapporteurs for the committee. I 
invite nominations. 
Alex Cole-Hamilton (Edinburgh Western) 
(LD): I nominate Brian Whittle.  
Clare Haughey (Rutherglen) (SNP): I 
nominate Maree Todd.  
The Convener: If there are no further 
nominations, do members agree that Brian Whittle 
and Maree Todd will become our rapporteurs? 
Members indicated agreement. 
Sport for Everyone 
10:01 
The Convener: The second item is a round-
table session on phase 2 of our inquiry into sport 
for everyone. We have just over an hour for the 
session and we have a number of guests with us, 
who are very welcome. I will introduce myself, 
then we will go round the table and everyone can 
introduce themselves.  
My name is Neil Findlay. I am a Lothian MSP 
and convener of the Health and Sport Committee.  
Clare Haughey: I am Clare Haughey, the MSP 
for Rutherglen. 
Alan Johnston (Senscot): I am Alan Johnston 
from Senscot, where I am the sport and social 
enterprise co-ordinator.  
Tom Arthur (Renfrewshire South) (SNP): I am 
Tom Arthur, the MSP for Renfrewshire South.  
Katherine Byrne (Chest Heart & Stroke 
Scotland): I am Katherine Byrne, policy manager 
at Chest Heart & Stroke Scotland.  
Malcolm Dingwall-Smith (sportscotland): I 
am Malcolm Dingwall-Smith from sportscotland. 
Alex Cole-Hamilton: I am Alex Cole-Hamilton, 
Liberal Democrat MSP for Edinburgh Western, 
and my party’s health spokesman. 
Alison Johnstone (Lothian) (Green): I am 
Alison Johnstone, an MSP for Lothian.  
Kenneth Ovens (Scottish Association of 
Local Sports Councils): I am Kenneth Ovens, 
chair of the Scottish Association of Local Sports 
Councils.  
Ivan McKee (Glasgow Provan) (SNP): I am 
Ivan McKee, the MSP for Glasgow Provan. 
Brian Whittle (South Scotland) (Con): I am 
Brian Whittle, an MSP for South Scotland and my 
party’s spokesman on health, education, lifestyle 
and sport.  
Allyson McCollam (NHS Borders): I am 
Allyson McCollam from public health in NHS 
Borders. I am here on behalf of a group of partner 
organisations that have made a joint written 
submission.  
Maree Todd (Highlands and Islands) (SNP): I 
am Maree Todd, an MSP for the Highlands and 
Islands. I apologise for my late arrival—I came 
down from Orkney this morning.  
Ewen McMartin (Volunteer Scotland): I am 
Ewen McMartin, Volunteer Scotland’s disclosure 
services manager. 
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Colin Smyth (South Scotland) (Lab): I am 
Colin Smyth, an MSP for South Scotland and my 
party’s spokesperson on public health and social 
care.  
The Convener: Thank you. We will try to keep 
the discussion as free-flowing as possible, so 
please indicate to me if you want to contribute. 
Members will ask a few questions as we go. We 
begin with Clare Haughey.  
Clare Haughey: I welcome all the witnesses. I 
will kick off. Can you provide us with examples of 
where sport has made a difference to communities 
or individuals, and tell us what evidence there is to 
show that it has made that difference? 
Kenneth Ovens: I am speaking as the chair of 
the Scottish Association of Local Sports Councils, 
but I am also treasurer of clubsport Berwickshire. 
One of our principal aims is to support athletes at 
the various levels, from the very local level to 
international level. We award grants according to 
the level. We ask them to supply us with 
information about how successful they have been 
after having received that money. We also support 
clubs whose facilities require upgrading, and we 
get feedback from them on how successful their 
projects have been. 
The Convener: Where do you get your money 
from? 
Kenneth Ovens: We get our money from Live 
Borders, which is a leisure trust. There are four 
sports councils in the borders—clubsport 
Berwickshire, clubsport Ettrick and Lauderdale, 
clubsport Roxburgh and clubsport Tweeddale—
and they are all given a percentage of the money 
from the pot, depending on the size of the 
population in the area that they administer.  
The Convener: Is that money received direct 
from the local authority?  
Kenneth Ovens: It goes from the local authority 
to the leisure trust, then the leisure trust gives it 
out. 
Katherine Byrne: The 500,000 people who 
have heart and lung conditions or who have 
suffered a stroke often aspire not to participate in 
sport, but to be physically active, which is hugely 
important in secondary prevention of further stroke 
or heart attack, or exacerbation of lung conditions. 
We know that there are enormous barriers to 
those people being physically active. Just last 
week, the Scottish household survey produced 
evidence that only 39 per cent of people who are 
living with long-term health conditions are able to 
be physically active, against the national average 
of 79 per cent. I want to highlight to the committee 
how important physical activity is to many people 
who are living with long-term health conditions. 
Although sport is important, it is very much a 
subset of that overarching physical activity. 
Alan Johnston: I echo that in respect of the 
sport social enterprise network of about 140 
organisations that I represent. It is as much about 
physical activity and the intention to make a 
difference to people’s lives as it is about sport. It is 
hard to pick out one particular organisation. There 
is the issue of affordability, as well: we need to 
make sure that people and families can afford 
activities. 
Allyson McCollam: I will continue on that 
theme—physical activity and the importance of 
widening access to it. In addition to the sports 
activities in the Scottish Borders that my colleague 
referred to, we have a number of initiatives that 
are promoted through partners whom we need in 
order that we can engage with some communities 
who might not be as able to access opportunities 
to be active. The initiatives include specific referral 
routes for people with long-term health conditions, 
and they include many more community-based 
activities in village halls and in local centres, which 
are very much appreciated by people who do not 
have access to leisure facilities, with transport 
being a particular issue in the rural areas. 
We hear a lot of positive reporting back about 
improvements to people’s wellbeing, reduction in 
social isolation and increased confidence. That 
applies across a wide age range, including older 
people. The understanding that sport and physical 
activity are closely interlinked is really important; 
some people become physically active then move 
on to being more engaged in formal structured 
sport of some kind. However, for a lot of people it 
is the increased level of physical activity that has 
the major impact. 
Malcolm Dingwall-Smith: At national level, we 
are seeing growth in the big programmes—in 
governing body club membership and in active 
schools membership—and in the physical activity 
benefits and the health benefits that come from 
that. 
At the micro level, we are beginning to see a lot 
of interesting work. For instance, Dalry community 
sport hub worked with 10 unemployed people to 
build up their skills. Of those 10 people, five of 
them went on to college, three secured places, 
several of them started volunteering and a couple 
of them have jobs now, as a result. There are 
large-scale health benefits, but we should not 
ignore the smaller benefits that come from 
communities looking at new and innovative work. 
Alan Johnston: A lot of work is going on 
around sport for change, which the committee will 
be aware of. Sport for change is a good way of 
demonstrating the difference that sports clubs and 
community clubs can make in relation to things 
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such as employability and social inclusion. There 
are projects addressing homelessness, for 
example. The sport for change research that has 
recently been undertaken and the work through 
sportscotland, which is taking a leadership role, 
can only be better for communities and population 
health. 
Clare Haughey: The committee is carrying out 
an inquiry into sport for everyone, so we are keen 
to highlight good work that is being done. What is 
the recipe for success in getting people physically 
active? I take on board Allyson McCollam’s point 
about physical activity and sport. 
Katherine Byrne: To pick up on Allyson 
McCollam’s point about the importance of 
community-based support, we have about 60 
groups across the country providing physical 
activity in a variety of forms. The groups are very 
much led by the local community and meet local 
needs. The groups might provide, for example, a 
walking group or a gym-based exercise class that 
is led by a qualified exercise instructor who can 
support people with health conditions. They may, 
for example, provide seat-based exercises for 
people with disabilities and older and more frail 
people. 
One of the keys to success is very much local 
peer-based support—people being able to go to 
groups with other people who are experiencing 
similar health conditions and being able to build up 
social networks as well, which is vital in keeping 
them attending regularly. 
Allyson McCollam: I will follow the theme. One 
opportunity for communities to work out which 
physical activities they would enjoy is participatory 
budgeting. A pilot on that with the Burnfoot 
community in Hawick—Burnfoot is an area of long-
standing high deprivation—was quite astounding. 
Although the funding did not have many 
conditions, many applications were related to 
physical activity and opportunities for particular 
age groups or within certain settings. They 
included a boxing-club breakfast for kids in school 
and an application to purchase bikes and provide 
cycling classes for children who did not have those 
opportunities in their families. The principle behind 
the pilot was striking, to me; it was important to 
give communities the resources to make choices 
about the initiatives that they would like, and not to 
constrain the range of activity to what we might 
think is preferable for that community. 
Brian Whittle: I will go on and say what I failed 
to say at last week’s meeting, about how we speak 
about “sport for all”. We have to be careful, 
because although a lot of physical activity leads on 
to sport, the majority of people who are physically 
active are not doing sport. That is why I asked last 
week about what we mean by “sport”. As we do 
our investigation, we have to bear that in mind. For 
me, sport is competitive physical activity, and the 
majority of people do not do that. Jogscotland, for 
example, is physical activity—it is not sport. Aqua 
aerobics or a class in the gym are not sport—they 
are physical activity. 
The Convener: Is it your view that activity is not 
sport if there is no competitive element? 
Brian Whittle: Correct; sport is competitive 
activity. Tell me I am wrong: show me an example 
where that is not true. 
The Convener: I play golf, badly. I do not play 
competitive golf. Therefore, that would mean that I 
do not play sport. 
Brian Whittle: I disagree. You do play sport: 
you try to beat the course every week. 
The Convener: What do other people here 
say? Tell Mr Whittle that he is wrong. [Laughter.]  
Malcolm Dingwall-Smith: Sportscotland takes 
a wider view of sport. For instance, in jogscotland 
if a person runs five kilometres every week, we 
would say that the person is competing against 
himself or herself to bring their time down. People 
do that activity for themselves, and it is sport.  
Different people view sport in different ways. 
The Scottish household survey says that 52 per 
cent of adults and 66 per cent of children have 
played sport in the past four weeks. That is the 
majority of people, but I agree that sport is not the 
answer for everyone, particularly when we are 
trying to get inactive people to be active. 
Clare Haughey asked what is the secret to 
getting people involved in activity. The answer is 
that there is no secret. School environments and 
active schools are involving children and young 
people more in the planning of sport and talking to 
them about what they want to do. Similarly, the 
community sport hub model is not a programme 
that is imposed from above; it is based on 
understanding what works in each community. We 
heard about that from Glasgow Life at last week’s 
meeting. 
Particular groups face barriers to sport—for 
example, people with disabilities or older people. 
Each individual sport needs to understand the 
barriers and what can be done. Sportscotland has 
been undertaking that work, but there is more to 
do.  
Alex Cole-Hamilton: I will pick up Brian 
Whittle’s point about whether physical activity is 
sport. As a surfer and a scuba diver, those are 
sports to me, but I do not compete. Anyone 
around this table who is a runner will run for 
pleasure and fitness. Running is a sport—we do 
not go to any section of a department store other 
than the sports section to buy our running gear. 
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The competitive edge speaks to a wider issue. 
We heard at the start of the meeting that only 38 
per cent of people with long-term conditions 
engage in any physical activity. That chimes with 
the experience on our field trips—in particular, to 
the Millennium centre in my constituency, where 
one person said that they are not engaged in sport 
because of embarrassment about being 
overweight and thinking that they would look silly 
in a track suit. 
There is also slight anxiety about the 
competitive nature of sport. We all have horrific 
childhood memories of being forced to compete 
and coming off badly. That is a barrier. I contend 
to Brian Whittle that competition has its edge, but 
the elite aspect of sport can be inhibiting. I would 
be really interested to hear the panel’s views on 
whether the elite aspect is a barrier—or a 
perceived barrier—to participation in physical 
activity. 
10:15 
The Convener: There are not many Official 
Reports that have sentences that start, 
“As a surfer and a scuba diver”. [Laughter.]  
Would anyone like to comment on what Alex Cole-
Hamilton has said? 
Brian Whittle: I would like to comment—I am 
actually trying to help here. Competitiveness in 
sport, especially when people are young, is a 
massive barrier to long-term participation in sport. 
That is where I am. Alex Cole-Hamilton will not be 
surprised to hear me say that I do not mind 
listening to his opinion before I tell him why he is 
wrong. 
We have highlighted an issue, in that our 
investigation has not nailed down what sport is— 
Alex Cole-Hamilton: It is a spectrum. 
Brian Whittle: For me, the fact that there is a 
variety of opinions on that question is an issue as 
regards what we are investigating. In my view, 
being physically active is what we should be 
looking at. 
The Convener: I want to raise the issue of 
funding and where we should put the money. We 
have heard from Allyson McCollam about money 
that goes to community projects at the grass roots. 
Throughout our deliberations, the criticism has 
been made of sportscotland that it concentrates 
too much on the elite level at the expense of 
grass-roots sporting activity. That criticism might 
or might not be legitimate. I would be interested to 
find out from the panellists whether they think that 
we are putting money in the right places to get 
more people active. 
Alan Johnston: I mentioned sport for change, 
through which a large piece of work is being done 
to look at sport and physical activity. Organisations 
including the Robertson Trust are looking to fund 
activity that is not just about elite sport. Mr 
Whittle’s point about competitiveness is important, 
but there are also the fun and social interaction 
that those organisations are keen to encourage. 
Sportscotland is starting to recognise that it is 
important to fund those aspects. 
The Convener: Yes—but we are trying to get at 
whether sportscotland is putting enough money 
into those aspects. Is the balance wrong? 
Alan Johnston: At the moment, sportscotland 
is not putting enough money into that, but I would 
like to say that it is trying to address that. 
Ivan McKee: This has been a great discussion. 
I would like to get the panel’s reflections on what 
the objective is. There is the proportion of adults 
who meet the physical activity standard— 
The Convener: Could I stop you there, Ivan? 
There are people who would like to respond to the 
funding question. I will bring you after that. 
Ivan McKee: No problem. 
Kenneth Ovens: The SALSC works with all the 
local sportscotland councils throughout Scotland, 
of which there are currently 38. We continually 
hear from them that the amount of money that 
they receive is decreasing every year because of 
pressures on local authorities and leisure trusts. 
Some sports councils are very good and have 
addressed the situation by looking at different 
ways of raising funds—for example, by working 
with companies to get sponsorship and so on—but 
one or two have decided that they cannot continue 
as they would like in supporting athletes and 
clubs. That is down to the pressures that they are 
being put under. 
Allyson McCollam: I am not sure whether this 
is a direct answer to the convener’s question, but it 
will not surprise the committee to learn that, from a 
public health point of view, I am particularly 
interested in the inequalities focus. One of the 
tensions that we are aware of locally is that the 
fact that the sports clubs and the trusts have a 
responsibility to maintain the facilities and 
premises that they have oversight of sometimes 
narrows the opportunities for them to engage with 
the wider community and provide opportunities for 
a range of community groups. There is an issue to 
do with overhead costs and the need to keep 
membership levels up. Maintenance of 
infrastructure is obviously important, but there is 
sometimes a tension between that and our efforts 
to stimulate wider engagement with physical 
activity for the whole population. 
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That is not insurmountable, but it is hard to 
quantify where the balance of the resources 
should go. It is easier to identify what is spent on 
sports facilities than it is to identify what funding 
goes into promotion of physical activity, because it 
is so diverse and is accessed and promoted 
through a wide range of funding streams and 
initiatives, which might not be badged as being 
directly about physical activity and might use the 
funding as a way to build skills, encourage 
volunteering and combat isolation. A lot of 
unintended benefits come through a lot of other 
routes. 
The Convener: Is there a deliberate policy to 
skew funding to benefit areas of most need? 
Allyson McCollam: There is not sufficient 
skewing. It is very difficult to do, but it would 
definitely be good to see more of it. 
Katherine Byrne: Funding is a systemic issue, 
in the sense that it extends beyond national health 
service care. After someone has had a heart 
attack or a stroke, or when they are diagnosed 
with a lung condition, they are provided with an 
NHS rehabilitation programme. Physical activity is 
a core component of those programmes. People 
who can access rehabilitation and complete the 
programmes are far more likely to be physically 
active months later and to sustain the benefits of 
that, but provision of rehabilitation is patchy 
among the health boards. We recently conducted 
a survey of pulmonary rehabilitation provision 
across the 14 regional health boards and found 
that there is capacity for only about 9,000 people. 
We estimate that around 69,000 people across the 
country would benefit hugely from such 
rehabilitation. 
Malcolm Dingwall-Smith: The committee will 
be unsurprised to learn that I have a different take 
on sportscotland’s spend. The majority of our 
budget goes on grass-roots sport, rather than on 
performance sport. I have followed the 
committee’s evidence taking, and I have heard a 
lot of references to the good work that the active 
schools programme and community sport hubs do. 
Those programmes are funded by sportscotland. 
In addition, we put money directly into clubs and 
coaches. We invest directly in 122 clubs, and we 
direct funded 3,300 coaches last year with 
subsidies for them to take coaching qualifications. 
We also put money out through the awards for all 
programme and facilities. 
The committee has heard evidence about 
whether money goes directly to clubs or to 
governing bodies and local authorities for staff. 
There is a balance to be struck. We can 
underestimate the value that an individual 
supporting a club can add. Especially for 
volunteers, who are time limited, support from a 
professional is sometimes of more use than direct 
subsidy. It is also important to note that we 
represent only 10 per cent of overall public 
spending on sport: 90 per cent of the sports 
budget is spent through local authorities. 
Brian Whittle: NHS Ayrshire and Arran has an 
excellent exercise programme for stroke 
rehabilitation in the community. There is fantastic 
evidence that it cuts readmissions. I just wanted to 
point that out. 
I will take up Malcolm Dingwall-Smith’s point. 
We seem to be focusing on the sportscotland fund 
when the overall sports budget goes 
predominantly to councils—£500 million is spent 
that way. I wonder what the committee’s view on 
that is. Have we looked at funding in the round or 
have we focused completely on the sportscotland 
budget? 
The Convener: Yes, we have looked at funding 
in the round—several times. We have taken 
evidence from various people who have 
highlighted the huge impact that cuts to local 
government budgets have had on grass-roots 
sporting activity and the ability of trusts and local 
government to fund projects direct. 
Brian Whittle: It is important that we look at 
funding in the round, because inequalities can 
probably be focused on more directly through local 
government funding and making it more targeted. 
Ivan McKee: My question is related to that and 
goes back to what we are trying to achieve. There 
is a metric in the national performance indicators 
for the percentage of adults who meet the 
recommended level of physical activity. That figure 
has been in the low 60 per cents for a number of 
years. My question to the organisations that are 
represented at the table is this: do you see that as 
your primary objective, as one of your objectives 
or as an objective that we should not be focused 
on at all. Are other objectives more important? If 
you think that it is important, what are you doing to 
move forward with the resources that you have? 
We have talked about the 37 per cent who do not 
meet that objective, and in hard-to-reach and 
disadvantaged groups the percentage is obviously 
going to be potentially much higher. How does that 
figure in your focus? 
Katherine Byrne: That is hugely important to 
Chest, Heart & Stroke Scotland. We have just 
launched a three-year initiative in which we will 
focus particularly on enabling the people whom we 
support to be more physically active in different 
ways. We will test new community support and we 
will pilot new ways of reaching more people and 
addressing some of the inequalities that Colin 
Smyth mentioned. 
I reiterate how important physical activity is for 
the people whom we support. Not only does it help 
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them to regain their lives—some people can be 
literally trapped in the house without sufficient 
support to be physically active—but people who 
are physically active are far more likely to 
participate in their community and build a network 
around themselves to self-manage their 
conditions. They are also less likely to be 
readmitted to hospital and to have to visit their 
general practitioner repeatedly, so there are 
savings to be made for the NHS, as well. 
Allyson McCollam: I had better come in quickly 
on the savings for the NHS, which is always a 
welcome message. We have heard quite a bit 
about rehabilitation, but I would like to highlight 
how important physical activity—and increasing it, 
especially among the most inactive people—is in 
relation to prevention. We know that a tidal wave 
of long-term conditions is likely to come at us if we 
do not do something soon, given the ageing 
population profile, the increasing prevalence of 
obesity and being overweight in Scotland, and the 
continuing low levels of physical activity among 
many people in various communities. 
In the Scottish Borders, we are beginning to 
look more at the role of physical activity as a 
preventative measure. We are looking at 
introducing a diabetes prevention programme to 
target groups of the population who are likely to be 
much more at risk; physical activity is one of the 
main ways in which we can engage with that 
population and make an impact. We have run a 
very promising small-scale pilot that has already 
shown significant gains in terms of clinical 
improvements for the individuals in it, who have 
reported a lot of very strong improvements in their 
health and wellbeing, their social connectedness 
and their sense of control over their lives. We see 
that as an area in which there is huge scope for 
development. An inequalities focus in that work is 
absolutely critical. 
Malcolm Dingwall-Smith: At 9.30 this morning, 
the latest health survey statistics were released. 
You are right that, there is still no statistically 
significant increase in adult participation in 
physical activity, but there has been a small 
increase. However, there has been a statistically 
significant increase in children’s participation, with 
76 per cent of children reaching the recommended 
level. It is interesting that there has been a 
particular increase in girls’ participation since 
2008, from 64 per cent to 72 per cent. 
We want participation in sport to increase by 
more than it is currently increasing. In our large-
scale programmes, we are seeing growth in sports 
participation. The picture is looking pretty positive 
for structured sport, but that is against the 
backdrop of an ageing population and changes in 
lifestyles and culture. We need to look collectively 
at how we can work to address that and adjust the 
design of sport. 
Brian Whittle talked about what does and does 
not count as sport. We are seeing more sports 
clubs offering different types of opportunities; they 
are offering a wider variety of activities and 
activities that are more likely to attract people in 
the door. I could reel off a list of examples, but I 
think that you have heard about a lot of them from 
our partners. 
The Convener: You mentioned large-scale 
programmes. Can you give examples? 
Malcolm Dingwall-Smith: Up to 290,000 
children are taking part in the active schools 
programme, and for governing body membership 
we are looking at 770,000 members of sports 
clubs. Those are the kinds of things that we are 
doing. 
The Convener: One programme that appeared 
to be really successful was jogscotland, but it had 
its funding chopped. Why was that? 
Malcolm Dingwall-Smith: Jogscotland is being 
funded. 
The Convener: Yes, but its funding was 
chopped—it is now being funded via the Scottish 
Association for Mental Health. 
Malcolm Dingwall-Smith: It is being funded via 
sportscotland, as well. It has received funding from 
SAMH, but— 
10:30 
The Convener: Was that a reversal of the cut? 
Malcolm Dingwall-Smith: It was a decision to 
put the funding in. Initially, jogscotland was funded 
directly by the Scottish Government, then the 
money moved to sportscotland. There was then a 
reduction in the funding. It was intended that it 
would be reduced it and there was an 
understanding that that would happen, because 
we were considering the programme’s 
sustainability. We have been working hard with 
Scottish Athletics on that. We believed, and had 
discussed with Scottish Athletics, that by the end 
of the previous financial year, it would be in a 
position to carry on without that funding, so we put 
a little bit of money in as a stopgap measure. At 
the beginning of this year, it became apparent that 
Scottish Athletics would not be able to continue 
the programme without that funding, so we put 
funding back in. 
The Convener: Did that have nothing to do with 
political pressure? 
Malcolm Dingwall-Smith: A number of 
politicians wrote to us to say that they had had 
discussions with their local jogscotland groups, 
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which told them that the programme was providing 
a valuable service and that it needed the money to 
carry on. They had identified the same gap. We 
welcome politicians taking an interest in local sport 
and raising the same issues as we heard about 
from Scottish Athletics. 
The Convener: Had that intervention not been 
made, would you have reinstated the money 
anyway? 
Malcolm Dingwall-Smith: Do you mean if the 
intervention by politicians had not been made? 
The Convener: Or if the Government, or 
whoever, was putting pressure on you. 
Malcolm Dingwall-Smith: The conversation 
that we had with Scottish Athletics indicated that 
the money was needed, so we put money in. 
Alison Johnstone: I will carry on with questions 
about the fact that there has been little change on 
achieving the latest recommended level of 
physical activity. Mr Dingwall-Smith spoke about a 
small increase in the number of adults who are 
achieving it and a more promising increase in the 
number of children who are. However, we seem to 
have been more or less stuck since 2008. What do 
we have to do to increase the figure? If we do not 
increase it, we will have a recommended level that 
far too many people are not achieving. Do you 
have any suggestions about what needs to 
change? 
Malcolm Dingwall-Smith: A really concerted 
effort across partners is needed on that. It is not 
just about sport; sport is a contributor to physical 
activity but not the only part of it. Physical activity 
includes active travel, active living, dance and 
play. All those different parts of physical activity 
need to come together. At the moment, there is a 
temptation to put the entire responsibility for that 
goal on sport, but all public sector organisations 
need to pull together with the third sector and the 
private sector if we are to make a real impact. 
Alison Johnstone: Sportscotland’s audit of the 
school estate showed that about 61 per cent of 
available indoor space in secondary schools is 
used during term time, which drops to 43 per cent 
during holidays. For outdoor space, the figure is 
even lower: obviously, there is a weather impact, 
but only 40 per cent of outdoor space is used 
during term time and the figure drops to 28 per 
cent in the holidays. We might expect that more 
spaces would be used more in the holidays. 
Also, 73 per cent of the space that is used is 
under a regular extended let, and those lets are 
difficult for community groups to access. They 
require people to make bookings and to get 
money together for them up front. The proportion 
of casual use is pretty low, at 26 per cent. Why is 
usage so low? That space is a huge asset for us. 
How can usage be increased? 
Malcolm Dingwall-Smith: A regular extended 
let will generally be held by a sports club or a 
community group and does not necessarily require 
up-front payment. Nevertheless, you are right: the 
audit showed that the level of accessibility is high. 
The ability to book facilities at some time is high—
something like 98 per cent of secondary school 
facilities are available at some time for community 
booking, although that availability is not 
necessarily consistent. 
Outside school time, schools are run by local 
authorities or, in some cases, by leisure trusts or 
other operators, so the challenge is potentially 
about the booking management systems. How can 
people book a casual let? In some cases, it is not 
as easy to book a badminton court in a school as it 
is to book one in a leisure centre, which is clearly 
a problem if we are trying to encourage 
accessibility. That comes down to working with 
each local authority or operator on how the 
management system can be improved, rather than 
just assuming that schools are not available. It is 
about how they are managed. 
Alison Johnstone: You said that, if we are to 
tackle physical inactivity, there must be 
partnership working, but we do not seem to have 
quite cracked that yet, when it comes to access to 
the school estate. One reason why usage is low 
during the holiday period might be that janitors are 
on holiday. In this day and age, we must be able 
to get together to come up with a model that 
makes such facilities available all year round. 
Malcolm Dingwall-Smith: Part of the issue will 
be to do with availability, but it will also depend on 
the model to which the school operates. Quite a lot 
of the schools in the Highlands are run by High 
Life Highland, which I think the committee has 
taken evidence from. That model gets round the 
janitor problem, because it uses a much larger 
staffing base. The fact that the staff can move 
between locations means that it is not necessary 
to rely on a janitor unlocking the door. Use is of 
the model that involves having a single janitor who 
is responsible for unlocking the door is decreasing. 
We are seeing less of that. 
It is a question of working across different local 
authority departments with whoever is responsible 
for running the school—a leisure trust or a 
different operator—understanding the needs of the 
community and understanding when it is useful to 
have a facility open. It is not always useful to have 
a facility open during the day even during school 
holidays, because there might not be demand for 
access from local sports clubs even though the 
school is potentially available. 
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The Convener: I liked your question, Alison. 
We have hospital wards closing and airlines’ fleets 
being grounded because they cannot manage 
holidays, and you expect janitors’ holidays to be 
sorted out. The naivety of it! 
The submission from NHS Borders talks about 
the school estate in the area being managed well 
when it comes to access. 
Allyson McCollam: I am afraid that I am not 
able to comment on that in any great detail, 
because it is not an area that I know much about. 
However, I am conscious that several new schools 
have been built, the arrangements for which have 
been much more flexible, so the issue has been 
factored in to encourage much more community 
use of the range of facilities. Looking forward, I 
think that the situation is more positive. 
Brian Whittle: I would like to go back a level. 
Does the panel agree that the best place to start 
tackling health inequalities is in school, because 
we have a captive audience there? Do you agree 
that, if we are to invest in tackling health 
inequalities, that is the obvious place to start? 
I also want to ask about the impact of the 
withdrawal of funds for compulsory free swimming 
lessons. I presume that you agree that, in order to 
participate in swimming, it is necessary to be able 
to swim. However, we know that about 40 per cent 
of kids go to secondary school unable to swim. If 
we are to tackle health inequalities, is the school 
estate where we should start? 
Allyson McCollam: We need to be aware of 
the limitations of that approach in rural areas. 
Although there are many opportunities in schools 
to improve health and to reduce inequalities, we 
also need to think about the family context and the 
community context. In the Scottish Borders, giving 
children more swimming lessons would not 
necessarily work, because not all of them have 
ready access to swimming pools at the weekend 
or outside school hours, simply because of the 
geography of the area. 
I think that the approach should be more about 
emphasising the importance of physical activity for 
not just children but all members of the community 
at all ages and stages, because the family is a 
huge enabler of such activity and helps to set 
patterns. School can have an impact, but unless 
parents—and, indeed, grandparents and other 
members of the extended family—are directly 
engaged in the process, its effectiveness might be 
quite limited. If we were to adopt the approach that 
Mr Whittle proposes, we would write off quite a 
large proportion of the population, to whom we no 
longer have access in school and whose health 
could be significantly improved within their lifetime 
if we did other quite simple things. 
Malcolm Dingwall-Smith: Curricular sports 
activity is not the responsibility of sportscotland. 
That takes me back to the point that I made 
earlier: all the partners must pull together. The 
issue that Mr Whittle raises would have to be 
taken up with Education Scotland and local 
authorities. That is why it is important for all the 
various parts of the public sector to get together to 
discuss how to increase physical activity and 
participation in sport. Some of that work has been 
done in the national strategic group under the 
active Scotland outcomes framework. However, 
concerning the committee’s inquiry, the decisions 
that it takes and the recommendations that it 
makes, there needs to be an understanding that 
sport is a pretty complex landscape and that a 
huge number of partners are involved in the 
different aspects of it. 
Colin Smyth: Allyson McCollam mentioned 
health inequalities. Do you come across 
inequalities in the work that you do? Are levels of 
participation—whether in volunteering, 
rehabilitation or particular sporting activities—
lower among people from more-deprived areas? 
What have you done to try to tackle such 
inequalities? Do you even measure inequality? Do 
you know, for example, how many of the people 
who come to your activities are from the most 
deprived areas? Is participation simply about the 
number of people overall, or do you measure 
where those people come from? 
Alan Johnston: Social enterprises that are 
rooted in the community do not gather a lot of 
statistics, so I am afraid that the information is 
more anecdotal. A lot of people look at things such 
as social impact, which I suppose is a different 
dimension. Most social enterprises are about 
working with people in deprived communities, 
sometimes because there is a lack of activity in a 
particular community—there could be an 
affordability issue, for instance. Social enterprises 
in this area are about addressing inequalities and 
ensuring that people have access to physical 
activity. 
Allyson McCollam: We asked people what 
gets in the way of their being more active and we 
identified that one of the main barriers is cost. 
Small costs can accumulate—people might have 
more than one child, or they might have to pay a 
bus fare as well as the entry fee to a facility. It is 
important not to underestimate that; even with 
some subsidy, cost can be an enormous barrier to 
people participating in sport. 
The growing interest in walking as a social 
activity is therefore interesting and important. We 
have talked a bit about jogging and jogscotland, 
and about some other sports. The paths for all 
programme has been really significant in engaging 
people from a range of backgrounds in walking 
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and making use of the environment around them, 
whether in a city or in a rural setting. In the 
Borders, we have at least 70 volunteers, who are 
supported by one part-time co-ordinator. Walking 
has a strong profile in the Borders, and there is a 
lot of engagement in it by a wide range of 
groups—which includes an increasing number of 
people with dementia—but we find it hard to 
gather the statistics that would give us evidence 
on which postcode areas individuals come from. 
People do not necessarily want to be monitored 
when doing an activity that is about enjoyment, 
pleasure and being active.  
Our sports and leisure trusts also have difficulty 
gathering information in a format that would help 
us to look at health inequalities from a public 
health point of view. However, evidence shows 
where the greatest inequalities are likely to be; we 
know which communities in the local area are 
most affected by inequalities and low levels of 
activity. We can put different sources of 
information together, but we cannot always say 
which communities particular users come from. 
The Convener: Colin Smyth mentioned 
volunteering. I have a question for Ewen 
McMartin. Are there barriers to people from 
deprived communities coming forward to 
volunteer, or problems with the number of people 
who are available to assist in setting up 
organisations? 
Ewen McMartin: I am afraid that that is not 
really my area of expertise—I work on the 
disclosure service side of things. The wider 
organisation is doing work based on the protecting 
vulnerable groups scheme data, but I am afraid 
that I cannot provide any details about that. 
Malcolm Dingwall-Smith: I agree with Allyson 
McCollam that the appropriateness of asking 
participants for certain information depends on the 
programme. An inactive person who walks through 
the door of a community sports club does not want 
to be asked a wide range of monitoring questions.  
We found that participation in the active schools 
programme is 11 per cent higher in schools with 
most pupils from the lowest 20 per cent of Scottish 
index of multiple deprivation areas than it is 
nationally in schools overall. One possible reason 
for that is that the majority of activity in the 
programme is free, so it is potentially more 
appropriate in those schools, whereas in other 
areas more young people might pay for activity 
outside the school environment.  
In some of our other programmes, such as 
community sports hubs, there are lots of great 
examples of activities being provided for people 
who could not normally afford them. At the Jack 
Kane centre here in Edinburgh, holiday 
programmes are provided free, along with free 
meals to tackle the problem of holiday hunger. 
There is great work going on locally. 
On monitoring, we do not have national-level 
data for that particular programme. However, the 
data that we have gathered on the active schools 
programme shows that the way that we are 
delivering it is working in deprived communities.  
10:45 
Maree Todd: I could not let the morning go by 
without mentioning that this is women and girls in 
sport week. 
We have seen a huge rise in participation in 
some sports in Scotland. Participation in karate 
and dodgeball has quadrupled and participation in 
cross-country running, tennis and rugby union has 
doubled over the past five years. Does anyone 
round the table have any ideas about how that has 
been achieved and how it might be transferred to 
other sports? 
I say to Brian Whittle that getting women active 
will have a massive impact on the activity level of 
whole families, and that of society. 
Brian Whittle: Correct. 
Malcolm Dingwall-Smith: The stats about 
karate and so on relate to participation in those 
sports within the active schools programme. We 
did a huge amount of work through a programme 
called active girls, which worked with every 
secondary school physical education department 
to get a better understanding of girls’ activity and 
to take a really participatory approach to planning 
it. 
We have also been looking at who is coaching 
sessions. Getting more young women involved in 
coaching helps to drive up the number of women, 
and especially young girls, who participate, 
because they see role models whom they can take 
after and approach. As I said, the latest health 
survey stats show the gap closing between girls 
and boys in terms of the number who meet the 
physical activity standards, which is great to see.  
Within the club and governing body sector, 
governing bodies of a lot of sports that have been 
traditionally seen as male dominated—which was 
perhaps not seen as a problem a decade ago—
are now really focusing on participation of women. 
As part of the equality standard for sport 
framework, which sportscotland runs, every sport 
looks at all its policies, procedures and culture and 
asks which groups are underrepresented in it and 
why. By using that approach, which covers not just 
gender but disability, socioeconomic inclusion and 
age, a lot of sports are now developing activities 
that suit audiences that did not previously attend 
their classes or clubs. 
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Katherine Byrne: It is crucial that we become 
better able to identify where the gaps are and how 
we can best support people who are less likely to 
participate in physical activity or sport, and to 
tackle that as early as possible. For the people 
whom we support, that might be at the point at 
which they receive NHS care; for others, it might 
be when they visit their general practitioner with 
health-related issues. 
Alex Cole-Hamilton: My question relates to the 
convener’s question about volunteering. Brian 
Whittle was absolutely right when he said that we 
have a captive audience in schools and 
classrooms, but not every young person at school 
is adequately engaged. I am speaking from my 
perspective as someone who was a volunteer 
youth worker for many years, and as chair of the 
cross-party group on volunteering. 
Over the past decade or so, we have seen a 
slow decline in youth work in this country—I 
mention in particular the closure of the community 
education department at the University of 
Strathclyde and the erosion of local authority 
budgets for detached and sessional youth work. In 
my experience, it is detached and sessional youth 
work that leads the hardest-to-reach young people 
to sport in the first place. Is that a rather bleak 
assessment? Are there examples of best practice 
in which youth work is flourishing in this country? 
Allyson McCollam: I can speak only for the 
Scottish Borders, where we have a vibrant youth 
work sector. YouthBorders works with the network 
of local youth work groups. Those groups work in 
close partnership with the council’s community 
learning and development service. That is all 
under the umbrella of our community learning and 
development strategic partnership.  
We have just been through an inspection, in 
which inspectors spoke quite highly of the 
examples of good practice that they saw. Physical 
activity is one of the range of opportunities and 
skill sets that we would hope to offer young people 
not just for the benefit of their health, but in order 
to achieve a range of other positive outcomes. 
The Convener: Is the budget there going up or 
down? 
Allyson McCollam: I could not comment. I 
would be surprised if it is going up, but I do not 
think that it is going down too drastically. 
The Convener: I would be extremely surprised. 
Could you let us know? 
Allyson McCollam: Yes. 
Kenneth Ovens: One of the indicators that is 
set for us by sportscotland is to encourage more 
young people to be involved in sport. We have 
taken it slightly wider than that, because not 
everyone takes part in sport or wants to take part 
in sport. 
We need councils and member clubs to run 
sports. We actively encourage young people with 
different skills, for example in social media or 
journalism, to become part of a sports council and 
to learn how to run one. In fact, we now have 
young people involved in 12 of our local sports 
councils and they are doing great work for the 
people. 
The trouble with sports councils is that because 
it is nearly all volunteers who run them, the 
average age is 60-plus. It is great to have a 
different view from 18 to 25-year-olds, which is the 
main age that we are looking for. They bring a 
different perspective on how sport needs to be run 
and what needs to be done with sport. We actively 
encourage people to become involved in that side 
of things. 
Malcolm Dingwall-Smith: Again, I am not well 
positioned to comment on funding for youth 
services in local authorities. In the past, a 
distinction used to be made between youth work 
on the one hand and sport on the other. There is 
more of an understanding now that sports coaches 
can be youth workers, and that youth workers 
deliver sport. We should not necessarily draw a 
distinction between them. At a strategic level, we 
work with Youth Scotland. However, Scottish 
Rowing is delivering a programme in the Firhill 
basin on the canal in Glasgow that engages young 
people who are disengaged with education and 
sport. The programme takes a youth-work led 
approach. 
Alex Cole-Hamilton: My experience of youth 
work is that the hardest-to-reach young people 
can be reached when positive relationships are 
established. Relationships are at the heart of 
youth work and, irrespective of the activity that is 
being undertaken, it is the relationships that 
germinate the interest. Relationships are 
important—they get young people to commit when 
they have perhaps never engaged or had staying 
power. 
I am glad to hear that the distinction has been 
blurred between youth work and sport. If it was felt 
that sports coaches were the sole arbiters and 
deliverers of sporting education, that might have 
been a barrier. In fact, some amazing detached 
youth work is going on there, with youth workers 
starting street football, street hockey and late-night 
boxing, which introduce young people to sport who 
would never have had the courage or social 
inclusion to join a club or try out for a team. 
The Convener: That was a statement, not a 
question. 
Alex Cole-Hamilton: It was. Am I not allowed to 
make a statement? 
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The Convener: You could finish by saying, “Am 
I correct?” 
Alex Cole-Hamilton: Or “Is that your 
understanding?” 
Brian Whittle: Perhaps we could tie the issue of 
volunteers into the Commonwealth games legacy, 
and the extent to which the legacy is linked to an 
increase in the number of volunteers. At the end of 
the day, if you are going to raise the number of 
participants, you have to raise the number of 
volunteers. I am thinking specifically about a 
programme that worked particularly well, which 
was the club together programme. For the benefit 
of the panel, the programme paid for a part-time 
position—15 hours a week—in clubs. Malcolm 
Dingwall-Smith can correct me if I am wrong, but I 
think that it was funded by sportscotland, the club 
itself and private funding. The cost was about 
£7,500 a year. Again, correct me if I am wrong, but 
I think that that has led to an increase of about 400 
volunteers into the sector and about 3,000 
athletes. Was the increase in volunteers part of 
the Commonwealth games legacy? 
Malcolm Dingwall-Smith: Scottish Athletics ran 
the club together programme, which was very 
successful. It built the capacity of clubs, because 
growing a club needs the people who run it—
coaches, administrators, safeguarding officers, 
treasurers and so on—to be able to increase 
capacity, deliver extra sessions and do the 
fundraising to support all that. Ahead of the 
Commonwealth games, Scottish Athletics took the 
conscious approach that a legacy would need the 
capacity to take on new participants. A lot of 
athletics clubs in Scotland have had good growth. 
On the wider question about volunteers and the 
Commonwealth games legacy, active schools 
have had a 50 per cent increase in the number of 
volunteers in the past five years. Whether that 
increase can be linked directly to the 
Commonwealth games raises a question of 
attribution. I think that Scottish Athletics used the 
phrase, “Legacy is what we do every day”—it is 
about all the bits of sport that are built into 
increasing the number of people who come 
through the doors of sports clubs across the 
country and ensuring that the infrastructure is in 
place to deliver. 
Brian Whittle: Similar to the Commonwealth 
games, 2012 was all about increasing the number 
of participants. With that target to increase the 
number of people who participate in activity, was 
the need for volunteers properly taken into 
account? 
Malcolm Dingwall-Smith: The answer is yes; 
you have given a great example of a sport that 
took that approach, and I know that it is not an 
isolated example. A large number of sports 
understood that they would need more volunteers 
if they were going to increase the number of 
people who played their sport. As I said, we 
actively qualify a huge number of volunteer 
coaches every year. 
To support sport to grow, we need to support 
the volunteering arm. We do that in a number of 
ways, through coaching subsidies and providing 
training to clubs to ensure that they understand 
how to manage volunteers. That is important, and 
I am sure that Volunteer Scotland might have 
more to say on the matter. It is not good enough to 
have a volunteer walk through the door then leave 
them to it. A club needs an ethos that understands 
how to support a volunteer once they are in place. 
Katherine Byrne: Chest Heart & Stroke 
Scotland does not have sporting volunteers, but I 
make the point that recruiting and retaining 
volunteers is a challenge to organisations across 
various sectors. We are one of the biggest 
volunteering organisations, with a workforce of 
around 1,600 people. Even then, we have to re-
recruit about 400 people every year because of 
the massive turnover. 
We have invested hugely in supporting and 
providing training for our volunteers, but key for us 
has been identifying the motivation for 
volunteering in the first place and playing to that 
as a strength. If people are looking for particular 
skills and experience, we try to give them that. At 
the moment, we are working with Queen Margaret 
University, which has a new degree course on 
physical activity and wellbeing. We will work with 
second and third-year students to provide 
volunteer placements where they will help our 
service users to be physically active and to 
participate in community-based activities. 
Clare Haughey: The panel will be aware that 
the committee has looked at the PVG scheme in 
relation to sports coaching, particularly in youth 
football. How does Volunteer Scotland view the 
current PVG scheme? Has it had any impact on 
volunteering? 
Ewen McMartin: About 266 sporting 
organisations access free PVG checks through 
our organisation; that figure includes the governing 
bodies that the clubs feed into. In the past year—
certainly since January up to September—there 
has been a marked increase in applications for 
PVG checks, which are up by about 200 per cent. 
The clubs know that they have to do the checks 
and the volunteers are aware that they have to go 
through the process and are more than happy to 
do it. The Scottish Youth Football Association 
obviously had a huge increase in PVG 
applications, given the situation that it found itself 
in last year, but the Scottish Rugby Union 
experienced an increase of more than 400 per 
23  3 OCTOBER 2017  24 
 
 
cent in the same period—January to September—
compared with last year. 
11:00 
Clare Haughey: What does your organisation 
put the increase in PVG forms down to? 
Ewen McMartin: The media coverage and what 
has had to happen—what organisations should be 
doing and what a regulated role actually is. 
Clare Haughey: Are you suggesting that there 
were sports groups that did not know that they had 
to— 
Ewen McMartin: We are certainly working with 
a lot of sports organisations to help them 
understand what they should and should not be 
looking to PVG check. 
Clare Haughey: Are you monitoring exactly 
who is currently putting in those applications? 
Ewen McMartin: Yes, we regularly do that, and 
I can provide the numbers to the committee. There 
is no problem with that. Those show where the 
applications are coming through. 
Clare Haughey: That would be very helpful, 
because you have raised a bit of a concern for me 
that organisations perhaps were not complying 
with PVG disclosure. 
Ewen McMartin: There was certainly a lack of 
understanding, as has become apparent. 
Clare Haughey: Who is responsible for 
ensuring that sporting groups and clubs have an 
understanding— 
Ewen McMartin: Well, understanding is their 
responsibility, but our organisation is there to 
support them, as is Disclosure Scotland. I can 
provide the details so that you can see where the 
numbers are. 
Clare Haughey: I am very keen to have a look 
at those. 
The Convener: You said that there has been a 
200 per cent increase in PVG applications overall. 
Ewen McMartin: Yes. 
The Convener: And there has been a 400 per 
cent increase from the SRU. 
Ewen McMartin: In the region of 400 per cent, 
yes. 
The Convener: I would contend that there has 
not been a 400 per cent increase in participants. 
Ewen McMartin: No, I would not have thought 
so. 
The Convener: Are you seeing similar 
increases in other sports? 
Ewen McMartin: There have been large 
increases in some other sports, yes. There is now 
an awareness; things are becoming more 
apparent and organisations are trying to get their 
houses in order. 
The Convener: If organisations are registering 
people for PVG who were not previously 
registered, and if they are doing that properly, with 
your guidance—if they are registering the right 
people, and therefore people who have no need to 
be PVG checked are not being PVG checked—we 
can only surmise that a large number of people 
who should have been checked were not checked. 
Ewen McMartin: Potentially, yes. 
The Convener: That is very concerning. I think 
that we need to get much more information from 
you about where applications are coming from, 
where the big increases are and why 
organisations were unaware that they had to PVG 
check people who presumably were taking part in 
regulated activity. 
Ewen McMartin: Yes, that may be the case. I 
can certainly provide the numbers—that is not a 
problem. 
Clare Haughey: Given the information that you 
have just given us, Mr McMartin, how many 
people did not pass PVG checks? 
Ewen McMartin: I do not have that number in 
front of me. 
Clare Haughey: That is a really important piece 
of information, which it is important for the 
committee to have quite quickly. 
Ewen McMartin: I would not be able to tell you 
who— 
Clare Haughey: I am not asking for individual 
names; I am asking for numbers for each 
organisation. 
Ewen McMartin: Okay. 
The Convener: I am somewhat surprised that 
we found out this information in this way. The 
committee really needs to follow up on why that 
information was not volunteered by Disclosure 
Scotland, or whoever. 
Ewen McMartin: The information came to light 
only when we picked up on and dissected the data 
that we have had in this year. 
The Convener: But had Clare Haughey not 
introduced that line of questioning, we would not 
have known. Was it the intention of Disclosure 
Scotland to write to the committee? 
Ewen McMartin: It was certainly my intention to 
pass the information on. 
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The Convener: Okay. We will most certainly 
write to seek that information. 
If no one wants to raise any final issues, I thank 
the witnesses very much for their attendance. We 
will suspend briefly for a change of panel. 
11:04 
Meeting suspended.
11:14 
On resuming— 
Technology and Innovation in 
Health and Social Care 
The Convener: Item 3 is the committee’s first 
evidence session on technology and innovation in 
health and social care. We have a number of 
guests, and we will start by introducing ourselves. 
I am a Labour MSP for Lothian, and I am the 
convener of the Health and Sport Committee. 
Clare Haughey: Good morning. I am the MSP 
for Rutherglen and the deputy convener of the 
committee. 
Professor Patricia Connolly (University of 
Strathclyde): I am the director of the Strathclyde 
institute of medical devices at the University of 
Strathclyde. 
Tom Arthur: I am the MSP for Renfrewshire 
South. 
John Brown (Scottish Lifesciences 
Association): I am the director of policy for the 
Scottish Lifesciences Association, which is a trade 
body that represents 140 companies in Scotland 
that do life sciences, including e-health. 
Andy Robertson (NHS National Services 
Scotland): Hello. I am the director of information 
technology at NHS National Services Scotland. 
We run most of the big national systems that 
support the health service in Scotland. 
Alex Cole-Hamilton: Good morning. I am the 
Lib Dem MSP for Edinburgh Western. 
Alison Johnstone: I am an MSP for Lothian. 
Elaine Gemmell (Scottish Health Innovations 
Ltd): I am head of project development at Scottish 
Health Innovations. We work with the NHS to help 
to commercialise innovation in the health service. 
Ivan McKee: I am the MSP for Glasgow 
Provan. 
Zahid Deen (Health and Social Care Alliance 
Scotland): I am digital health and care strategic 
lead at the Health and Social Care Alliance 
Scotland. 
Brian Whittle: Good morning. I am an MSP for 
South Scotland. 
Professor Christoph Thuemmler (Edinburgh 
Napier University): Good morning. I am a 
consultant physician, a general practitioner and a 
professor of e-health at Edinburgh Napier 
University. 
Maree Todd: I am an MSP for the Highlands 
and Islands. 
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Alex Matthews (PA Consulting Group): Good 
morning. I work for PA Consulting; I lead our 
digital work in health and social care in Scotland. 
Colin Smyth: I am an MSP for South Scotland. 
The Convener: I am sorry—it was remiss of me 
not to mention that members might have some 
interests to declare. I declare that a close relative 
of mine works for a company that is involved in e-
technology. Does anyone else have a declaration 
of interests to make? 
Brian Whittle: I am director of a technology 
company that creates collaboration and 
communication platforms for organisations, 
including healthcare organisations. I no longer 
receive remuneration from that company and do 
very little work with it at the moment. 
The Convener: Who would like to ask the 
opening question? 
Brian Whittle: I will start with a very general 
question. How easy is it for new technology to 
make its way into working practice in the NHS? 
Professor Connolly: There are several routes 
in in Scotland. There is the SLA and its help with 
Healthcare Improvement Scotland. There is a 
route through the universities—a knowledgeable 
small company or a very large company can get in 
by finding the right clinical connections. The 
academic groups can do that. 
The problem goes beyond that. As soon as such 
technologies get proved or CE marked—in other 
words, ready for market—the barriers to uptake 
become very high. I think that we are quite good at 
setting up the initial research programmes, but I 
think that we are very bad at implementing our 
own technology in Scotland. 
Alex Matthews: I will answer the question in a 
different way. Under certain circumstances, it is 
incredibly easy to introduce new technology into 
the NHS in Scotland. We have direct evidence of 
having worked with NHS Education for Scotland to 
do just that. We implemented a live system to help 
to manage the education and training of trainee 
doctors in just four months. My answer is that it is 
incredibly easy to introduce new technology into 
the NHS; it is just necessary to have the right 
conditions in place. 
Professor Thuemmler: I am a little surprised 
by Alex Matthews’s answer. My experience from 
years of working in the NHS is that the situation is 
more as Patricia Connolly described it to be. It is 
not really that easy to get new technology into the 
NHS. The more complex the technology is, the 
more complex the process will be, simply because 
of the structure of the NHS. 
In my opinion, what is lacking is a 
comprehensive policy approach in Scotland, and 
we need to talk about that. We need to be more 
detailed in our planning of what we want, because 
technology is moving forward rapidly. I appreciate 
that Alex Matthews might have been talking about 
certain specific technologies that could indeed 
have been introduced in four months, but when it 
comes to key technologies that are relevant for 
things such as tagging, tracking, managing 
patients and managing pharmaceuticals, we do 
not have the right technologies. At the moment, 
we have a very difficult process for trialling such 
new technologies and implementing them, and 
that has economic implications. 
John Brown: Five years ago, the Government 
launched the innovation partnership; in fact, Ms 
Sturgeon launched it when she was the Cabinet 
Secretary for Health and Wellbeing. My 
organisation was given the job of delivering the 
partnership, and we partnered about 180 
companies with more than 1,000 clinicians, who 
were self-selecting early adopters.  
The outcomes are starting to come through to 
the procurement level. I would not say that it has 
been easy—I agree with Christoph Thuemmler’s 
remarks—but it has been a mechanism to help. 
Where we find a barrier is after that, even when 
the NHS has bought a new device. We have 
specific examples of that barrier; in one case, NHS 
procurement bought 30,000 devices that were 
better for patient outcomes and cheaper than 
existing products, but then they were put in a 
warehouse in Lanarkshire and there was silence. 
We call the issue of getting the information across 
adoption and spread. You can do all the research, 
prove that a device works and have a bunch of 
eager clinicians, but unless you do adoption and 
spread across the board, the result can be a damp 
squib.  
The Convener: If those devices are still lying in 
a warehouse, who is held accountable for that? It 
is a huge waste of public money. 
John Brown: They are not complex devices.  
The Convener: What are they? 
John Brown: They are drain tubes for surgery 
with a clever novel way of adjustment so that they 
are not stitched into the patient’s body. 
The Convener: Why are they sitting in a 
warehouse? 
John Brown: The reasons are information not 
being available, the fact that people have always 
used the old devices and the fact that the 
suppliers of the old devices are quite keen not to 
have their market taken away. 
The Convener: Who is accountable for that? 
John Brown: We have had a meeting with the 
NHS director of strategic sourcing—  
29  3 OCTOBER 2017  30 
 
 
The Convener: Is he accountable? 
John Brown: He is very interested in the 
device. 
The Convener: The issue is not who is 
interested. Is he the person who commissioned 
that contract and who is, therefore, accountable 
for that decision? 
John Brown: I do not work for the NHS but, 
from my viewpoint, the answer to the question is 
yes. 
Tom Arthur: What sums of money are you 
talking about? 
John Brown: In this example, the devices cost 
pennies—maybe £1.50 or something similar. It is a 
piece of low-tech but very useful innovation. It is 
patented and the NHS was very good about 
saying, “Yes, we will buy 30,000.” However, 
adoption and spread is the issue; how does the 
information get out for whatever it is—it might be a 
simple piece of plastic or it might be a complex e-
health system. 
The Convener: Is the example that you have 
given repeated in many other areas? 
John Brown: Yes; I could give you other 
examples. 
The Convener: Will you write to us with more 
examples? 
John Brown: Yes, I will. 
Tom Arthur: You mentioned the cost. In terms 
of clinical application, what is the impact on patient 
outcomes if this method is not being used? I 
presume that patients are losing out. 
John Brown: We have evidence from the NHS 
assessment organisation, which is called the 
Scottish health technology group. It has assessed 
the device and has written a positive report; the 
device was cost effective, the patient outcomes 
were better and they recommended it for NHS 
procurement. We were delighted with that and 
thought, “That’s it,” but—  
Elaine Gemmell: I come at this from a slightly 
different viewpoint. I stand beside the NHS and we 
look at the innovation that originates within the 
NHS and how it can be rolled out more widely. We 
find a willingness to innovate; the facilities to make 
that happen are very good in the NHS. We can go 
in and work with companies and bring expertise to 
bear.  
John Brown alluded to the fact that, once a 
product is available that we are looking to roll out 
more widely, it becomes more difficult. There is 
certainly an area where success is not 
disseminated and practices are not shared as well 
as they could be. Attacking this more at national 
level might lift some of those barriers. 
Maree Todd: I really just have a comment. As 
politicians, we do not often hear pleas for things to 
be centralised, but a common theme in the written 
evidence is that variation at health board level 
causes a challenge on the ground, and that 
centralising commissioning and distribution would 
be a good thing. That is a challenge for us, so I 
wonder whether the witnesses would like to 
comment on that. 
Elaine Gemmell: There is an appreciation in 
the community that lots of people can play a very 
important role. If criticism has been levied in this 
environment, it is that there is some confusion 
about the roles of organisations. Each 
organisation has an important role to play, and we 
would like there to be a co-ordinated effort to 
define roles and responsibilities, and to facilitate 
organisations coming together and working in a 
complementary way. 
Professor Connolly: When we talk about 
centralising, many people envisage committees 
and large structures in the centre. The problem 
with centralisation, or at least with introducing 
similarity across the NHS, goes to front-line staff. 
Many of us will have experience of devices for 
patient monitoring in the home or the community. 
There tends to be enthusiasm for such things 
among certain groups, who can see cost or time 
savings—there tends to be what we call “pilotitis”, 
where everyone wants to pilot a bit of something—
but I have to say that we tend to get kick-back 
from front-line clinical people. That is partly 
because digital medicine, e-health and personal 
monitoring are very challenging. They challenge 
both the clinician and the patient—and they 
monitor both, too. If a community group tries to 
introduce something without having a mandate for 
doing so and several nurses in the group do not 
want to use it, it will never be adopted. There will 
be no uniformity, and it will be very difficult for that 
group to get the business change mechanism. 
For example, I have a device that saves time on 
wound care. However, unless a nurse uses 
electronic nurse management to manage their day 
and says, “I don’t need to see that patient because 
the results say that it is okay, or it is diabetes or 
blood pressure,” the current paper-based system, 
in which a nurse takes their bag out for the day, 
makes it very hard to change things. Digital 
technology is making fundamental changes to 
everything from diary management to who picks 
up results and who monitors what is happening. It 
is introducing centralisation and similarity, but in a 
different way. 
The Convener: More pilots than Ryanair, 
perhaps. 
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Elaine Gemmell: Yes. It is also very important 
to ensure that we look at requirements and that 
things are implemented across the board. It is very 
easy to implement something that is suitable only 
in a small geographic area. If implementation is 
opened up to a much wider area and it is 
managed coherently, we can ensure that the 
solutions that are put in place are suitable across 
the board rather than just in niche areas. 
Andy Robertson: NSS spends a lot of time 
doing centralised activities. To take Alex 
Matthews’s point, certain conditions make things a 
lot easier when new innovations and technologies 
find their way to NSS. For example, it is easier 
when there is sponsorship by national bodies and 
when connections are made back into all the 
different health boards that are looking to deploy 
such technologies.  
We have a proposal, which we put in our written 
submission, for a service that might support a 
single process—a funnel, if you like—for new 
technologies to find their way to the front line and 
provide the support that such initiatives require.  
11:30 
It is a question of being able to get beyond 
procurement law and beyond governance, and of 
being able to get the funding for implementation 
and the support models that go with it. Funding for 
the tail needs to be obtained on an on-going basis. 
Often, funding is provided for the initial 
deployment of a new technology, but in order to 
run that technology for the health service, five or 
10 years’ worth of funding needs to be made 
available to support it. The boards struggle on a 
daily basis with the sheer volume of the demands 
that are placed on them, and they need to be 
helped to implement change as they do the day 
job. Some central support needs to be provided. I 
do not think that we are saying that a central 
organisation should deliver the new technologies, 
but there is certainly a role to be played in 
supporting the boards. 
The Convener: What you have described 
appears to be a very cluttered landscape involving 
numerous hurdles that have to be overcome 
before a new technology gets to patients. Given 
the speed of technological development, are we 
not in a position in which much of the technology 
that is implemented will be yesterday’s news by 
the time it has got through that whole tortuous 
process? 
Andy Robertson: Many of the controls that are 
in place are there for fairly good reasons; they are 
to do with things such as value for money, 
sponsorship and the willingness of boards to 
deploy. John Brown gave an example of the fact 
that there is no point in us buying new technology 
if the health boards are not willing to deploy it. We 
cannot control that, but we can certainly support 
the introduction of such technology. However, that 
takes time. 
I am sure that I am not telling members anything 
that they do not know when I say that the NHS is 
an extremely complicated organisation. It covers 
many different clinical disciplines and comprises 
22 health boards and 170,000 employees. There 
are 3,500 different locations on the end of our 
network. I can understand why people would have 
the impression that there are many hurdles, but 
that is because of the organisation’s complexity 
and the governance structures that sit underneath 
it. 
The Convener: Could all of that be radically 
streamlined? 
Andy Robertson: I think that it could be. 
The Convener: Is there a willingness to do 
that? Is there evidence that that is happening? 
Andy Robertson: I think that it is happening in 
places. Alex Matthews touched on this earlier—it 
is probably wrong to create the impression that 
nothing new is happening in technology in the 
NHS. That is extremely unfair. We are currently 
working on a number of things on a number of 
fronts. 
The Convener: I do not think that anyone is 
suggesting that. 
Andy Robertson: No, but committee members 
could perhaps come away with the impression that 
nothing new is making it to the front line, and I 
think that that is not true. 
Professor Thuemmler: I understand everything 
that Andy Robertson says, but the problem is that 
new technologies evolve, and they evolve on a 
global scale through globalisation. I understand 
that the NHS has all the problems that have been 
described, but the technology developments that 
we are talking about will not wait for the NHS. We 
need to find pathways that will help us to evolve 
and develop such technologies in Scotland for 
economic reasons, and then implement them in 
the NHS. We cannot take new technologies from a 
grass-roots level into the NHS and wait until they 
evolve at the speed of the NHS because, by that 
time, they will be yesterday’s news, as the 
convener said. That will never work. We tried that 
in the past, and it did not work. 
Andy Robertson: There are risks in throwing 
200 pilots at clinicians who are up to their necks in 
high levels of demand and who already have to 
deal with technologies that do not integrate with 
the existing platforms. Introducing a level of 
change that interferes with operational delivery will 
not help. There is no single right or wrong answer. 
We need to get the balance right. To respond to 
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Neil Findlay’s point, there is an opportunity for us 
to look at how we streamline the process and 
make it more effective than it is at the moment. I 
am not denying that there is a need to do that. 
Elaine Gemmell: We have touched on the 
length of time that it takes to develop such 
technologies and how quickly they change, but it is 
also necessary to look at how long it takes for new 
devices and technologies to get regulatory 
approval for implementation. At the moment, it 
takes an inordinate length of time for an 
examination of a technical file to be carried out. A 
company could have all the evidence ready to get 
something on the market as a CE-marked device, 
but it might have to wait six to nine months for a 
notified body to come and do the approval 
process. 
Ivan McKee: First, the convener’s interaction 
with John Brown about the new devices that are 
stuck in a warehouse may get to the core of the 
problem. The initial reaction was to ask, “Whose 
fault is it? Who do we blame? Who bought this 
stuff that nobody is using?” Surely, the person who 
bought the stuff was doing the right thing by taking 
a risk, which is a key part of innovation. The 
problem is not there; the problem is with the roll-
out of the stuff and how to engineer that. If we go 
back and blame the person who bought it, nobody 
else will buy anything new ever again, which will 
mean that we do not move forward. That mindset 
is critical to moving the innovation agenda forward, 
in my experience. 
Secondly, there are ideas about innovative 
technologies that I assume could save money, 
make processes better and more efficient and 
mean that people get through the lists quicker—I 
assume that they tick all the boxes that health 
board managers would want to deliver on. There is 
no shortage of health board people who come 
here and tell us that they have not got enough 
money and resources to do stuff. If they are under 
that pressure, you would think that they would fall 
over themselves to adopt ideas or products that 
make things more efficient. Something is clearly 
missing in the chain of how people see their role 
as health board managers or directors that means 
that they do not grab that stuff and run with it. It 
might be their awareness of what is going on or 
their ability to execute policy in their boards. The 
panel may want to comment on that. 
The last question that I will throw out is on what 
Elaine Gemmell talked about. Can somebody map 
out for me the pathway for innovative ideas? If I 
am a health service employee who works in a 
ward and has a good idea—probably not a high-
tech idea, but perhaps an idea about how to 
reorganise the way in which things are laid out, do 
something a bit differently or change the 
information flow—how do I get that idea through 
the process? Who do I talk to and what do they do 
with it? Where does it go and how do we trial it? 
Unless you have innovation and continuous 
improvement bubbling up from the bottom, and 
unless people feel that their good ideas will be 
taken forward, you will not innovate or make 
improvements. 
The Convener: The witnesses have only 43 
questions to answer. [Laughter.] 
Ivan McKee: I have waited for 15 or 20 minutes 
to get in, convener. 
The Convener: Everyone wants to get in—that 
is the issue. 
Elaine Gemmell: I will address the last question 
first. Scottish Health Innovations was set up in 
2002 specifically to work with the health service to 
identify innovation that happens in the health 
service. When we started, we asked people about 
innovation and they told us that they did not 
innovate because it was not their job. Over the 
years, we have used evidence to build a pathway 
for them to get those ideas through. Four of the 
major health boards are represented on our board, 
and we work with the 14 health boards under a 
service level agreement. We have a relationship 
with each health board’s research and 
development department, and, if an employee has 
a good idea, the first port of call will be their own 
management, who will direct them to the research 
and development department or, in some 
instances, to Scottish Health Innovations. 
We will evaluate the idea to determine whether 
it is useful and innovative. If other things might 
answer the same question, we point people in 
their direction. If it is truly an idea that should be 
developed for better patient care or better ways of 
doing things, we will pull together a team of people 
to take the innovation from the first idea right 
through the whole process. We will help with 
advice and resource and, eventually, by finding 
partners who will take it on to the market. 
The Convener: Does that address the issues 
that you raised? 
Ivan McKee: I am happy with that answer. Are 
there any comments on the other issues that I 
raised? 
John Brown: I have talked about the 1,000 
clinicians who work with 200 companies. They are 
the early adopters, but they are busy clinicians 
who see the point of innovation and want it. They 
are also happy to work collaboratively. The other 
people who get it are the top management of the 
NHS. Paul Gray, the chief executive, had a career 
in Government IT and really understands the 
issues. 
One block or barrier is a lack of management 
support for innovation, which is not yet in the job 
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description of senior managers in boards. Those 
1,000 clinicians do this work off the end of a busy 
workload. Rather than rely on their goodwill, the 
healthcare system needs to fund a bit of clinician 
time to work on innovation with collaborators. That 
happens in many places, but it is not done yet in 
Scotland. The work relies on altruism or on 
clinicians who are interested in innovation for its 
own sake and find it enjoyable to work with 
companies to develop new products, but you 
cannot depend on that to create a system that will 
pick up innovation and implement it across the 
board. 
Christoph Thuemmler: We are speaking a lot 
about the NHS and what we can do within NHS 
structures, but it is also important to consider 
parallel universes. For example, at the moment, 
there is a lot of discussion about information 
technologies, mobile technologies and other new 
communication technologies such as 5G. Those 
technologies are the future. On a European level, 
they are being pushed forward, and there will be 
early prototypes in America in 2020—they are 
already on the way. 
Those technologies will be essential to the way 
in which we will treat patients over the next 
decade or the next 20 years, so we need to talk 
about them. What we are doing at the moment is 
good—we are talking about the NHS, what is 
working or not working and how to get innovation 
out of the NHS—but we also need to look a couple 
of years into the future, otherwise we will all be on 
the back foot.  
England invests double-digit million figures in 
that technology, whereas we have not a penny 
available in Scotland at the moment, so we are 
completely cut off. Those things need to be 
discussed. You cannot look at health technology 
as a single standing issue, because, in the future, 
we will treat more and more patients outside 
hospitals—that is a fact. When we do that, there 
must be connectivity with the point of care, which 
will shift out of the NHS and into the patient’s 
home, so we need communication technologies to 
connect in order to deliver the next generation of 
healthcare. It is important to look a little bit ahead 
rather than discuss what has happened over the 
past few years and where we stand. 
Alex Cole-Hamilton: I am interested in how 
decisions are made about adopting tech in the 
health service. During the summer recess, Alison 
Johnstone and I made a fascinating visit to the 
cancer research centre at the Western general 
hospital in Edinburgh, where a guy was testing 
drugs with a new machine that looked like a fish 
tank. It cost £250,000 and allowed him to do his 
job 67 times faster than he used to do it because 
of the number of drugs that he could test in a day. 
That led me to wonder about the parameters that 
are put around decision making on such 
technologies. What is the fulcrum over which a 
decision is taken to invest in that kind of tech or 
innovation against its not being cost effective? 
I am conscious that we do not operate in a 
vacuum. Tech companies are lobbying clinicians 
and decision makers to choose their brands and 
are extolling the virtues of their machines. Can I 
have some views from the panel on how those 
decisions are currently taken? What parameters 
are used to decide, and are we getting it right? 
Professor Connolly: I wanted to follow on from 
what Christoph Thuemmler said. We must be 
cognisant of what is going on elsewhere. Apple 
now has a complete med tech division and is 
promising such innovations as glucose sensors on 
its watches. There are commercial developments 
that patients want to access, and they will push us 
hard. Justine Ewing mentions Push Doctor in her 
submission. With Push Doctor on your phone, for 
£20 you can get a face-to-face consultation with a 
qualified GP and a prescription if you need it. I 
read every weekend about the locum problems all 
over Scotland and the millions of pounds that are 
being spent on locums, and I wonder why we 
cannot take some subscription to Push Doctor for 
patients through NHS 24. That would probably get 
rid of many of the actual go-and-see patient 
problems. 
Those are commercial developments, and I 
know that it is a bit taboo to be considering them. 
We are rightly proud of our NHS, but we must look 
at areas where companies have developed the 
right solution rather than do it from scratch. That is 
true for much of the home monitoring, which is 
another area that we will come on to. 
The other thing that we are falling behind with 
on that side is our innovation pipeline. We are not 
funding devices and med tech development in 
Scotland as we should be. I work with people 
around the world—in Hong Kong, Singapore and 
the United States—who are building up large 
wealth packages because they are developing 
companies and research projects together. We 
really have fallen behind. 
11:45 
Going back to Alex Cole-Hamilton’s question 
about decision making, if a company has a very 
large piece of equipment such as a surgical robot, 
it can apply to the health boards. It would need 
very good cost-saving arguments, but big 
companies perhaps can do that. It may be worth 
talking to companies such as Medtronic about 
that. 
With small and medium-sized enterprises and 
more day-to-day stuff, it depends on whether they 
have clinical opinion leaders and whether they can 
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push through clinical barriers—people’s natural 
resistance to changing their way of working. 
Imagine that a big organisation is trying to roll out 
a piece of human resources software. In the NHS, 
everyone gets to try the software and say, “I don’t 
like it. I’m not using it in my job.” We might have a 
complex clinical management need, but everyone 
is empowered to say yea or nay to new pieces of 
technology, so things become difficult. That is a 
natural human reaction—I understand that push-
back. 
Zahid Deen: On innovations that come from 
elsewhere, we must recognise that, although the 
third sector is a major innovator in both digital 
health and digital care, there are few—if any—
examples of its working with or connecting into the 
NHS and social care. That is partly because it is 
seen not as a partner but as a safety net, whereas 
it actually provides a third of social care services 
and does a huge amount of clinical research. That 
issue could be addressed by giving the third sector 
a seat at the table, including on decision making. It 
needs to be considered as part of the fold, not as 
an afterthought. 
Andy Robertson: The answer to the question is 
that adoption is highly situational—it depends on 
the technology and the linkage into the clinical 
community. A new piece of technology is normally 
picked up by clinicians. If a national organisation is 
involved, technology has a better than average 
chance of being adopted, but governance of the 
adoption of new technology is, by default, at the 
board level. If a decision is made to adopt 
something nationally, a layer of national 
governance will be put in place to oversee its 
deployment board by board. If a piece of 
technology passes that initial threshold—if it is 
picked up by people who are willing to sponsor it 
through the health service and push for it to 
become a national programme—things become a 
bit more straightforward. 
The Convener: There is a rough guide to 
lobbying in the NHS and getting products through 
the system. 
Andy Robertson: I am sure that there is—or 
there should be. 
The Convener: You just gave us it. 
Alex Matthews: I will not comment on the 
decision-making process, but we need to 
recognise that, although it is often easy to identify 
ways to save clinician time, translating that saved 
time into a cost saving is complicated. At the heart 
of the issue is the ability to take a clinician time 
saving and translate it into a better balance 
between health and social care that achieves a 
shift away from hospital, residential or locality-
based care towards care in people’s homes, 
whereby people take more responsibility for their 
own healthcare and start to self-diagnose, self-
treat and engage a little more in their care. 
Alex Cole-Hamilton: I am grateful for that. 
Committee members are all too aware of pharma 
companies’ efforts to lobby MSPs to exert such 
influence as we have on the Government in 
respect of its dealings with the Scottish Medicines 
Consortium and the licensing of drugs. Tech in the 
health service is commodity based—it is about 
selling goods to the health service.  
Last year, the Parliament passed the Lobbying 
(Scotland) Act 2016, which will tighten up the rules 
on lobbying parliamentarians. How pervasive is 
lobbying from tech companies that are trying to 
sell their equipment to the NHS, and how effective 
is that lobbying? 
Andy Robertson talked about the situational 
aspect of adoption. Where do we need to tighten 
up the rules in that regard? 
John Brown: Before I respond to your second 
point, I want to respond briefly to your first. It is 
about adoption and spread. Your example is about 
adoption; the issue is spread. To go back to Andy 
Robertson’s point, as long as that happens board 
by board, it will not be easy.  
A once-for-Scotland approach would be a great 
step forward. If NHS Greater Glasgow and Clyde, 
which is the biggest health board in Europe, 
decides that technology A saves it a lot of money, 
why do the other 13 boards get to say, “We’re not 
interested”? That happens; it is the sort of thing 
that we get all the time. A once-for-Scotland 
approach— 
The Convener: It might be that NHS Greater 
Glasgow and Clyde is wrong. 
John Brown: It might be, but it will have 
evidence to back up its decision. 
The current approach leads to siloisation. We 
are a tiny country. The NHS in Scotland looks after 
a population that is smaller than that of Yorkshire, 
and the current approach is not optimal, at least in 
terms of the uptake of new technology. 
A big global company with a big budget can 
afford to lobby. One of the things that drive me is 
the Scottish economy, and Scottish companies are 
nearly all small companies and cannot afford 
lobbyists. They develop stuff and work with 
clinicians, and they do what they can to spread the 
word about what they are doing. I agree that hard 
lobbying by big pharma—we have big pharma 
members—can be counterproductive; sometimes 
big pharma deserves that. 
Most Scottish companies are trying to develop a 
home market. If, when their salesmen go to the 
United States and are asked how many of their 
products they sell in their home market, the 
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answer is “none”, the people in the US say, “Well, 
why should we buy it?” Most life sciences 
companies in Scotland are small or medium sized 
and do not lobby, because they cannot afford to. 
Rather, they work with clinicians to try to get the 
message across. 
Alison Johnstone: Professor Thuemmler, you 
talked about how essential connectivity will be in 
future if we are to treat more and more people 
away from traditional clinical settings. Concerns 
have been raised about security and privacy when 
it comes to sharing the electronic patient record. In 
your submission, you referred to 
“Bad press related to unauthorised data dissemination, for 
example the case of the Royal Free in London which did 
pass on rich patient data to Deep Mind”. 
PA Consulting received some negative press a 
couple of years ago regarding the uploading of 
data sets on to a Google tool, and potentially 
uploading patient data to offshore servers—I know 
that you maintain that you safeguarded that data 
appropriately. 
People have concerns about privacy and 
security. You said: 
“Central databases are susceptible to malignant attacks 
such as ransom attacks”. 
You also said 
“A comprehensive merger of all existing information into 
one centralised data base will be almost impossible.” 
You described a tendency towards 
“Uncritical and uninformed procurement with excessive 
spending on technology consultants”. 
It seems that there is a lot that we are asking 
the NHS to get its head round—we are almost 
asking it to be in the vanguard of digital security. 
Do we have the staff to do that? Are we training 
people appropriately? Are we always going to be 
running to catch up? 
Professor Thuemmler: Thank you for the 
question. We all know that there are issues to do 
with security—I need only remind you about the 
WannaCry attack. Of course, these are the risks 
and issues that go with centralised databases. 
If we are talking about the electronic health 
record, the question is this: what do we have in 
mind? What are we looking at? The future is not 
the electronic health record, because we still have 
and will always have—even more so in future—
distributed databases. They are growing 
everywhere like mushrooms—at the different NHS 
trusts, at GP practices, at dentists, at pharmacies 
and at physiotherapists. The problem is that we 
will always have distributed databases rather than 
a database that sits in one computer. That is not 
so bad, actually, because it gives a little bit more 
protection. Imagine if all that data were in one 
supercomputer. Even if that machine were 
mirrored into different locations, if it came under 
attack, it would be a huge problem. You do not 
necessarily want that. That is why we will see 
more and more distributed healthcare and, 
consequently, more distributed databases, and 
that is why we need modern communication 
strategies. That is extremely important. I cannot 
stress enough the importance of the developments 
around those new technologies—5G and so on. 
In answer to your question about how many 
staff and how much effort and so on we need, I am 
not telling you anything new when I say that the 
NHS is a 70-year-old organisation that works in 
almost the same way that it worked back in the 
1940s. Of course we need to think about new 
strategies for managing it. We have to look into 
how the big technology companies, such as Apple, 
do these things. Big organisations such as Apple 
and the pharmaceutical companies are basically 
going into the health market—industrie fordert so. 
Those organisations do not want to sell technology 
devices; they want to provide services in the 
future. We have to get our head around the fact 
that in the future many services will be provided by 
third parties and integrated in organisations such 
as the NHS. Therefore we need a new strategy 
and a new structure—it is inevitable. 
Andy Robertson: I agree with Professor 
Thuemmler that the electronic patient record 
needs to be distributed; that is precisely the policy 
that we have been pursuing for some years. There 
is currently no one big central database for the 
health service. The WannaCry attack—which I 
came to the committee to explain the details 
behind—had nothing to do with databases and 
how data was distributed. 
We have been pursuing a policy for some years 
now on these technologies, but it is very difficult 
for us to pursue the things that 5G will bring to 
bear when some parts of the country do not have 
3G and some parts do not have fibre to the 
cabinet. As we try to keep up, we have to consider 
that to some extent there is a least-common 
denominator with the NHS. 
With regard to the companies in other countries 
that are investing, we put 2 per cent of our NHS 
revenue into IT, but the US, where Apple and 
some of the bigger companies are, is at 6 per cent 
and above. In general, we are struggling to keep 
the lights on with the complexity that we already 
have. Innovation brings another layer that will 
need to be funded and supported from a change 
management point of view. 
I am happy to explain what we have done in 
terms of the architecture of the systems in 
Scotland. We have not pursued the Big Brother 
approach of having a big centralised database. 
We are trying to move things to the cloud and 
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adopt the new technologies, but it is complex and 
is going to take us time. 
The Convener: I saw Professor Thuemmler 
smile wryly when Andy Robertson said that the 
WannaCry attack was not a database issue. 
Professor Thuemmler: It is true that the 
problem was that the Microsoft files were not 
updated, because the update patches had not 
been loaded. It was a database problem, although 
not one caused by a technical issue; it was caused 
by human error because someone had not 
updated. 
I agree with the point that Andy Robertson made 
about spending on IT, although the absolute 
figures that the NHS spends on IT are quite 
significant. Where I struggle to agree is when he 
says that we cannot think about 5G when some 
parts of Scotland do not even have 3G. That 
would mean that we would always live in the past, 
and Scotland could never evolve to top technology 
simply because it does not have 3G in some 
areas. I would dispute that, because we need to 
play in that upper league in order to give our 
technology SMEs a chance. They cannot develop 
if we do not have the infrastructure. It is not 
necessarily an NHS issue—the problem lies in 
digital. We put a very strong emphasis on health, 
but we also need to talk about digital health. 
Where is our infrastructure? How can we convince 
the telecoms operators to provide technologies 
such as low-power wide area networks? They 
have that in England but we do not—why is that? 
In a way, that holds us back. 
12:00 
Alison Johnstone: Mr Robertson, do you think 
that spending only 2 per cent of revenue on IT is 
inefficient? Does that have to increase? 
Andy Robertson: It inevitably needs to 
increase. The strategy for the digital 
transformation of the health service is under 
development right now—it is due in December. 
We are at the stage at which you have to invest 
more in IT to get returns in your business. That is 
not to say that the NHS has to spend more, but I 
think that we have to spend more on technology 
and innovation in order to fund the service 
transformation that has to take place. 
Brian Whittle: I am interested in the adoption of 
technology in the Scottish NHS compared with its 
adoption in the global marketplace, because 
technology is never developed just for the Scottish 
market. With that in mind, we have developed a 
digital health and care institute in Scotland that 
was specifically designed to enable the testing of 
new technology followed by its adoption by the 
Scottish NHS. Do panel members have any 
thoughts about whether that has been productive 
or whether there something is else that it should 
be doing? Should it be working differently? 
John Brown: I will answer the last question 
first. We have been tracking the work of all the 
innovation centres over the past six years. Three 
of them are in the life sciences area, including the 
DHI. We talked to our members in digital health, 
one of which—Sitekit—is based on Skye. 
Campbell Grant, its owner, was part of the DHI 
board at the beginning. I will speak carefully 
because I know that I am on the record, but let us 
just say that the innovation centres have not 
delivered the economic benefits that the Scottish 
Government wanted them to deliver five years 
ago. There are reasons for that, which I can go 
into in detail. 
The Scottish economy is another aspect, along 
with Mr Whittle’s point about comparison with 
other healthcare systems. Some of you will know 
that new mothers get a post-natal document called 
the red book. About three years ago, Sitekit, which 
is based on Skye and has an Edinburgh office, 
developed an e-red book and tried to sell it to NHS 
Scotland. The lead clinician loved it but 
procurement was an issue. 
Campbell Grant is now selling that e-red book 
very successfully to English health trusts. They 
seem to have managed to get to a place where 
they can take on such innovations, and Campbell 
has now opened an office in London with a lot of 
software engineers. He is a proud Scot; he comes 
from Skye and I do not think that he is going to 
move his company to London soon, but—as our 
submission says—if we do not crack the issue 
within the next few years I do not think that we will 
have a digital health sector left in Scotland. It will 
go where the market is. 
The Convener: Maybe you could write to us to 
follow up the issue of why those innovation 
centres have not delivered. 
John Brown: I am happy to do that. 
The Convener: Does anyone else want to 
come in on this issue? 
Professor Thuemmler: We have dealings with 
the DHI, the basic idea of which is good. I also 
want to be careful here. At the university level, we 
are involved in global 5G research. I am the 
convener of the health vertical at the Institute of 
Electrical and Electronics Engineers, which is a 
worldwide engineering association with more than 
a million members. I am also the convener of the 
health vertical at the 5G Infrastructure Public 
Private Partnership, which is a European initiative. 
We are linked into that, but the contributions so far 
to any 5G work at Napier is zero—zero from the 
Scottish Government, and zero from the DHI. I 
know that Strathclyde is also struggling. 
43  3 OCTOBER 2017  44 
 
 
As I said, the money that goes from the English 
Government to English universities looks 
completely different. We are talking about a first 
wave of double-digit figures in the millions, with 
the prospect of hundreds of millions over the next 
year being distributed to three universities. In 
Scotland, the investment is zero. I hope the 
situation will change, but that is where we stand. 
Clare Haughey: I want to pick up on a point that 
Patricia Connolly made earlier. It sums up some of 
the discussion that we have had today about how, 
although we can procure a lot of this new 
technology, getting staff and clinicians on the 
ground to use it can sometimes be challenging, 
even if we adopt a once-for-Scotland approach. If 
we have so many local variations, even within 
health boards—some surgeons operate in one 
way and some operate in another even within the 
same department—how do we get clinicians to 
accept and adopt new technology and use it in 
their practice for the benefit of the health service 
and their patients? 
Professor Connolly: Business change is a real 
issue and the NHS needs to address that. We 
have been doing some work with John Jeans, who 
advises the Prime Minister’s office on medical 
technology and chairs the DHI. He is very 
medtech savvy and has been around the industry 
for many years. We have been looking at some of 
the things that are coming up. 
People are busy in the NHS. When someone 
wants to save time by putting in more monitoring 
that patients can use for themselves in the 
community, there is really nobody with the 
expertise to do that. I would create a team in 
Scotland to fund the universities and work with 
them to bring on their companies and 
technologies. It would analyse the situation and 
spend some time and money on changing, for 
example, management at home or diabetes 
chronic care. 
We need to send in a business change team as 
well as the clinical team. When something is 
implemented well in a small community, it can be 
rolled out and mandated as the way to do things, 
once it has been proved that cost savings have 
been made in the area. 
I am sure that, like me, Christoph Thuemmler 
and many others have talked about this many 
times. How do we get over the barrier? It will mean 
taking a different type of look. I would also get 
providers—the Apples and Googles and so on—
involved. There might be some incentive for them, 
or some funding could come from them. They 
could make money in lots of different ways, such 
as from adverts rather than from selling services 
directly. 
If people are happy using social media and 
different types of monitoring to interact with some 
of the big providers we should not be afraid to start 
thinking outside the box about how we make 
savings. 
Elaine Gemmell: It is also important to 
understand that certain requirements have to be 
satisfied. We must not underestimate how 
important it is for the end users to be part of the 
development process. They have to be on the 
ground and invested in the innovation as it moves 
forward. That means that you have an invested 
stakeholder who wants the innovation to be a 
success. 
You then have key opinion leaders who can 
take innovation and roll it out to their colleagues. 
They can underpin all the— 
Clare Haughey: I am sorry to interrupt you, 
Elaine, but you are using a lot of jargon—“key 
stakeholders”, “end users” and so on. Could you 
use plain English, please? 
Elaine Gemmell: Apologies. People who are 
going to use the technology need to know why it is 
useful for them. What will it do for them? What 
improvements will it make for them? 
If they are involved in the process of developing 
that new technology, rather than having a solution 
imposed on them, they will be much more likely to 
be invested in using it. 
Clare Haughey: Are you talking about clinicians 
or patients? 
Elaine Gemmell: For this particular question, I 
am talking about clinicians, who will see a benefit 
from it. 
Clare Haughey: How do we do it, then? I 
suppose that the committee is looking for some 
answers. 
Elaine Gemmell: We talked earlier about there 
being lots of people in the innovation landscape 
who can brings lots of different skills to bear. It is 
important to realise that the NHS also has a 
significant role to play in that and should be part of 
a development team. The technology in industry 
and SMEs is part of the jigsaw puzzle, but the 
clinicians in the NHS, working from the inside out, 
also have a role to play in showing what will be 
required in infrastructure, training, how technology 
will fit with current practice, and any changes to 
care pathways. If clinicians are in at the beginning, 
the technology will develop in a way that is helpful 
for the people who are going to use it. 
Zahid Deen: The people who access the 
services also need to be at the heart of the 
process, so that we build solutions that address 
real rather than perceived needs. That is called 
co-design: it is an approach that understands 
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people’s needs and involves them in creating 
services, rather than build something that no one 
is going to use. We have a great example of that 
in our project called our GP. We have collaborated 
with more than 1,000 citizens and practice staff in 
creating three innovative GP digital services, 
which are there for potential implementation. 
Thinking about adoption, we need to consider 
the awareness of digital health and care among 
the public and ask what people know about it. In 
England, where they have made access to GP 
digital services pervasive, there is still very low 
take-up, because most people do not know that 
those services exist. We must consider marketing 
and what will happen to raise public awareness 
and change the way in which people think about 
how they access the NHS. 
We must also consider what we will do about 
the digital skills that people need to access 
services. The fundamental statistic is that a third of 
people with long-term conditions do not use the 
internet. How will we bring them on board, and 
how will we do that in a way that does not increase 
or exacerbate health inequalities? 
We can consider structures, clinicians and the 
NHS, but until we involve and consider people, we 
will not solve the problem. 
Alex Matthews: I agree with everything that 
Zahid Deen just said. We have started to pull out 
some points from Clare Haughey’s question and 
we have come to the point that Patricia Connolly 
made earlier. The technology that we need to 
deliver better health and social care is becoming 
increasingly commoditised and as a result is 
becoming easier to buy. That has moved the focus 
on to the other things that we have been talking 
about, such as decision making, technology 
selection and work to develop and implement the 
technology and deliver the business change 
around it.  
One of the things that we see most commonly is 
that the skills, capability and capacity to do that 
work are not readily available in the NHS and 
other health and social care organisations. For 
me, the key is, first, to ensure that those skills and 
capabilities are made available, so that we can do 
the work to select and implement the technology, 
and secondly, to build on that on an on-going 
basis, so that health and social care organisations 
can take responsibility for delivering technology 
themselves. At the moment, that is something that 
does not happen as much as it should. 
Professor Thuemmler: You make a very 
important point. It is clear that the NHS as such 
does not have many of the skills that are needed 
to come up with the technologies that we are 
talking about and envisaging. We need to 
somehow build those collaborations with the skills 
that we have in Scotland. We have excellent 
universities with departments that have skills that 
could be more than useful to development and 
implementation but we are not making enough use 
of those skills and resources that we have. It is 
important that we bring together the resources and 
skills that we have in Scotland to manage the 
processes. 
John Brown: I want to pick up on Ms 
Haughey’s question and I am afraid that I am 
going to use a bit of jargon. There are two barriers, 
one of which is called clinician autonomy: the 
doctor can take the decisions that she or he thinks 
are the right ones for the patient, no matter what. 
You might say, “This new way of doing it is much 
better and it costs half as much”, but the doctor 
might say, “That doesn’t matter. This way works, I 
know it works and I am not going to change my 
mind.” That is not an insurmountable barrier, but 
you have to know that it is there in order to work 
out how to get past it. 
Another barrier is service redesign. Many new 
technologies and innovations need the whole 
process to be redesigned. Christoph Thuemmler 
said that we need expertise in taking on innovative 
systems, but I would go further. The previous chief 
executive of NHS Scotland said to me, “This is like 
trying to redesign and rebuild an aircraft while it is 
flying.” Doing the service redesign while the 
service is still helping patients is a very tough job. 
However, I see well why you are looking for 
solutions. One idea with which we have toyed is 
that boards should be given, dare I say it, an 
aspiration—I will not use the word “target”. 
Somehow or other, the adoption and spread of 
innovation should be part of what boards are 
expected to do and, if they do not do it, questions 
should be asked. At the moment, that does not 
really happen. 
12:15 
The Convener: I will come back to that point in 
a minute. 
Professor Connolly: I will echo what Zahid 
Deen said and talk about the users. If we look at 
the adoption of technology for self-monitoring, we 
find that when we put such technology in patients’ 
hands it is well received. 
In our submission, we mentioned the piloting of 
NHS Florence. All that somebody needs to do to 
be monitored by the Florence app is to be able to 
text and answer some questions or take a fairly 
simple measurement on an instrument. 
Overwhelmingly, the patients really like the 
system, whether they are monitoring diabetes, 
blood pressure or heart failure. We have also 
tested it a little bit for wound care. However, it is 
becoming difficult to disseminate the app because 
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it pushes the clinicians into a different way of 
working. They need to decide who will look at the 
Florence results and who will talk to the patient if 
they need to talk to a clinician. 
There are barriers for patients. One is that we 
are not providing them with access to such 
technologies to find out how they can improve—
and how their mental wellbeing improves, too, 
when they feel that their chronic condition is being 
monitored. 
Maree Todd: I will ask about some of the 
cultural barriers to the use of such technology in 
the NHS. I was looking particularly at the attend 
anywhere pilot. I am a Highlands and Islands 
representative and it is key that we cut down on 
journeys to hospitals for routine out-patient 
appointments. We need to do that systematically. 
It will save us huge sums of money and save us 
flights. As a busy working mum, I know that it will 
enable people to be a lot more productive while 
they interact with the healthcare system. However, 
I am disappointed to see that only one patient was 
enrolled in the pilot in six months. 
The technology is not new at all and it is not 
difficult to use. The barriers must be cultural. 
There must be barriers among the patient group, 
who expect to go to see a doctor face to face, and 
barriers among the doctors, who like to have 
patients in front of them. The savings and 
improvement in service are obvious and the 
technology is not even new, so if we cannot get 
people to adopt new technology for the attend 
anywhere pilot, how will we get them to do that for 
anything? 
Andy Robertson: I am familiar with the attend 
anywhere pilot. It has not been that bad. I think 
that the example that you got from one of the 
submissions was a particular surgery where there 
was uptake of only one, but it has proved quite 
popular with clinicians. 
It is helpful if we can identify technologies that 
become popular with the clinicians, who then have 
to amend their back-end way of working. That is 
the business change element that we spoke 
about. Clinicians see the attend anywhere platform 
as being helpful to them in the short and long 
term, especially in remote and rural locations, 
where such contact becomes quite critical. In fact, 
we have taken that technology and put it into 
secondary care now: GPs are using it to contact 
secondary care clinicians to help them with the 
assessment of patient results. 
There is an inevitable march of technology when 
we put such measures in place. Admittedly, the 
attend anywhere platform is not advanced 
technology, but it is a big step forward for a GP 
who is trying to manage a broad base of patients. 
Some patients like it, but some like going to their 
GP, if that is the point that you are making about 
culture. However, we need to stick with such 
technologies and ensure that they are available 
and that we give patients choices as technology is 
adopted throughout the country. It would be wrong 
to give up on such innovations and put them on 
the back burner. 
Zahid Deen: Maree Todd raises an interesting 
point. We should not just dump technology on the 
NHS, on clinicians or on other people. A lot of 
investment is needed in change management and 
the softer stuff—the cultural change that is 
required, the training and the time to understand 
the technology and how to use it properly. It is 
about changing processes and changing thinking. 
That investment is not taking place; it needs to 
happen across the spectrum. We are just putting 
money into the hardware and the software; we are 
not putting it into those softer elements, but the 
success lies in doing that. We have lots of 
innovation and technology, but it has not been 
rolled out and it is not being used. 
The Convener: We have taken evidence on 
NHS governance, which is another area that we 
are looking at, so we know that in the current 
climate, where budgets are declining, people have 
less time for training and for doing things like this. 
What we are hearing here ties in with the evidence 
that we have taken. 
Professor Thuemmler: Just a word of warning 
on the systems that we are talking about here—
telemedicine, basically. There is a problem, in that 
medicine is not only see, speak and hear. 
Medicine is touch, feel, and smell—everything. I 
can say from a physician’s perspective—indeed, a 
GP’s perspective—that if I can only see a patient I 
might miss out on a lot. I love patients to be close 
by so that I can assess them through touch, feel 
and so on. I can then make an assessment and go 
through a whole process so that I can really get a 
result. 
However, there is progress on that front. We are 
talking about things such as the tactile internet, 
where you can remotely touch people. I am sure 
that more of these things will come. I make the 
point again that without communication 
technology, such things are not going to work. 
There are reasons why these technologies do not 
experience an explosive uptake, but I think that 
they will come. It will just take time. We also need 
to build on our digital infrastructure to enable 
them. 
The Convener: I was looking at the dictionary 
definition of “innovation”. It says, “a new method, 
idea, or product”. Innovation has a positive 
connotation, but some innovation might not be 
positive. For example, years ago, you would have 
to physically walk to the doctor to make an 
appointment. Now, you phone up. However, if you 
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have to phone 96 times to try to get an 
appointment, as one person recently reported to 
me that they did, that is not necessarily a positive 
innovation. 
I use that as an example to make the point: are 
we evaluating current practice adequately to 
assess whether innovation is needed to improve 
services or is just trying to patch a hole in the 
system? 
John Brown: I will talk about innovation in 
relation to medical devices. My information is that 
well over 40,000 different medical devices are in 
use every day by NHS Scotland. The Scottish 
health technologies group, which is the bit of the 
NHS that does the assessment—much as the 
SMC does for drugs—has probably assessed 
about 60 of those over the past five years, since it 
was set up. That is a very rough assessment but it 
is of the right order of magnitude. 
You touched on assessment; the scale of that is 
an issue. The SHTG has developed a fast 
assessment method called the innovative medical 
technology overview process, which is a maximum 
12-week programme. We like it very much, 
because SMEs find it easy to use and it gives 
them a fast response. Sometimes the most useful 
response is, “We will never buy that.” It is good 
that they know that quickly so that they do not 
waste money trying— 
The Convener: This is for devices— 
John Brown: Yes, it is for devices. 
The Convener: And where does it fit in with the 
Medicines and Healthcare products Regulatory 
Agency? 
John Brown: One aspect of the assessment is 
that you have to have an EU regulatory marking 
for your product. That is taken as given. 
Maree Todd: It is similar to the way in which the 
SMC acts on pharmaceutical products. The MHRA 
licenses the devices and then the SHTG— 
The Convener: And then the SHTG makes a 
decision on whether a device goes into the NHS. 
Is that how it works? 
John Brown: Yes. A company that tries to sell 
the NHS something that does not have a CE 
marking will not sell it. Everyone understands that. 
Professor Connolly: For clarification, I note 
that the SHTG does not say whether a company 
can sell to the NHS or not. There was maybe a 
misunderstanding about that. 
John Brown: The NHS will never buy anything 
that does not have a CE marking or other 
regulatory approval. The assessment of whether 
an innovation will pay for itself and will deliver—
the things that we are talking about round the 
table—is difficult because of the scale. Most of the 
40,000-odd devices that have been sold to the 
NHS are in use, even some of the more innovative 
ones. However, the innovative medical technology 
overview process is a huge step in the right 
direction. 
The Convener: So we do not know whether 
devices will provide value for money or do what it 
says on the tin. 
John Brown: For most of them, that may be the 
case. 
Professor Connolly: Maybe I can say a bit 
more, as somebody who is connected to an SME 
and works with other SMEs and bigger 
companies. Most companies put an enormous 
amount of effort into gathering evidence on the 
benefits of devices and doing calculations on the 
health costs. Papers on that are provided to the 
NHS by the companies, and most devices will not 
move to sale unless they can show such benefits. 
I think that the problem arises when, whether 
they have those papers or not, every group in the 
NHS wants to pilot devices for itself. That is an 
exhausting process for staff and everybody else. 
However, it would be unfair to say that the medical 
devices industry does not put great efforts into 
providing information on the efficacy and costing 
of its devices. 
The Convener: We have seen costings with 
regard to how some devices impact on patients, 
and unfortunately they show very high costs as 
well. 
Elaine Gemmell: Working with the NHS, we 
have created an innovative environment that lets 
clinicians and healthcare workers come to us with 
ideas for innovation. We have a responsibility to 
make sure that that goes on and that ideas can be 
developed into things that will be useful. 
We have talked about very specific ideas that 
will work in one geographic area but not 
necessarily in a wider area. Part of what we do is 
a very full evaluation of proposed technologies 
before we determine whether they should be 
developed further. That brings in whether the idea 
is a good one, whether there is already a solution, 
whether the company is trying to solve a problem 
that has already been solved in other areas, what 
the intellectual property position is, and whether 
the technology is currently available. All of that will 
happen before we start to develop IP. 
As things stand, we move forward with only 
approximately one in 10 of the innovations that 
come to us from the NHS. There is always a good 
reason or explanation as to why we will not move 
forward with an innovation. Sometimes it is just 
about putting people in contact with areas where 
development is already going on, because we do 
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not want to reinvent the wheel. That brings me 
firmly back to the idea that, if there is a co-
ordinated effort towards innovation, we can 
identify pockets, put people together and help 
them to work towards a solution, rather than 
having many different solutions in place 
throughout the country. 
The Convener: Can I clarify something? An 
innovation goes through that process, and then 
ultimately it has to go to each health board for 
analysis. After going through the process, it then 
has to go through another 14 processes. 
John Brown: Even if a company has SHTG 
endorsement or a big green tick from the 
innovative medical technology assessment, it still 
has to sell most products board by board. There 
are big strategic procurements that are done 
centrally, but— 
The Convener: Each board will review the 
papers and all that stuff, so there are another 14 
rounds to go. 
John Brown: Yes. That is the spread issue. 
Maree Todd: Is that similar to the SMC process 
for pharmaceuticals? A company gets a central 
approval for use of a drug in NHS Scotland, and 
then each health board assesses it and decides 
whether there is a role for it within its area. That 
happens quite routinely within a certain time after 
the central pronouncement. 
John Brown: There is a similarity. As far as I 
know, the NHS would not take on a drug in 
Scotland unless it has been through the SMC 
process—unless it is a cheap generic or 
something like that. 
Maree Todd: The fundamental difference with 
the technology assistance is that it can get through 
without the central assessment. 
John Brown: Exactly—and there are so many 
of them. 
The Convener: I am sorry; we are running very 
short of time. I want to give everybody an 
opportunity to make one final comment. A number 
of points have been raised and the discussion has 
been very interesting. This is a very clichéd way to 
do it, but that is me: if witnesses want to get their 
tuppenceworth in to develop the future strategy, 
what is the key point that you want to put in? We 
will go round the table. 
12:30 
Professor Connolly: I would ensure that the 
innovation pipeline from university through to the 
NHS is properly funded, as the university end, in 
particular, is neglected. With that funding, I would 
ensure that patient groups are brought in as real 
end users to help in the development and testing 
of products and incoming technologies. 
John Brown: We have pretty good strategies 
and we do not need another one. We need to 
make the ones that we have work. I support a one-
liner that Andy Robertson drafted in the NSS 
submission to the committee: 
“At the heart of the main failures”  
of strategy  
“has been the inability to translate the strategy, governance 
and relationships into consistent widespread delivery”. 
That is at the core of everything that we have 
talked about. We have strategies most years, but 
seeing a change is what matters. 
Andy Robertson: The systems and 
infrastructure are a sound foundation—I am not 
sure whether that has come through today. As I 
said earlier, if we truly want to be innovative and to 
change and transform the NHS’s services, we 
have to look at different methods of investment to 
bring new technologies into our environment. 
Governance and linkages to the academic world, 
and a different flow, with a recognised single 
funnel for innovations, can all be done on the back 
of the new strategy. 
The Convener: What do you mean by “different 
methods of investment”? 
Andy Robertson: The e-health funds that are in 
place today are the 2 per cent of NHS revenue 
that goes to IT. If that cannot be bolstered, we will 
have to look at other ways to bring in investment 
to support the deployment of new technology. I am 
not sure whether that would count on reductions in 
cost in other parts of the health service that 
technology could support or whether it would be 
new investment from Government decisions, but 
we need that increased investment to be able to 
bring innovation to bear faster than it does today. 
Elaine Gemmell: My message to leave you with 
is this: do not underestimate the innovative nature 
of the NHS and the talent and ability to innovate 
that is within it. Clear roles and responsibilities are 
important, as is an innovative environment to help 
to coordinate all the various bodies that can help 
innovation. 
Zahid Deen: I echo what Patricia Connolly said 
about co-design being needed as part of the 
strategy, so that people and the third sector are 
involved in creating and designing solutions.  
The previous strategy did not have an 
implementation plan, and that is why we have 
failed to see the progress that we want. We did not 
know who was to deliver what, or when it was to 
be delivered by. We still do not have any 
widespread national patient-facing service, not 
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even for online booking of appointments or repeat 
prescriptions—that cannot continue.  
We need coordination on innovation; we need a 
national innovation lead or someone who will take 
this issue strongly and help to coordinate all the 
partners who are involved. 
The Convener: Is leadership the key thing? 
Zahid Deen: Absolutely. 
The Convener: That is a point that we did not 
get in, but we should have done. Time has beaten 
us. 
Professor Thuemmler: I have been asked to 
clarify 5G PPP—it is the 5G Infrastructure Public 
Private Partnership, which is a European 
technology programme that is running between 
2012 or 2013 and 2020. 
We need to have another look at how the NHS 
R and D development funds are distributed. It 
does not make sense that each trust tries to 
develop its own things. Even if development is 
controlled by agencies on an NHS-only basis, we 
need to enhance the collaboration of the NHS with 
outside companies, such as SMEs and Scotland’s 
universities, as Patricia Connolly has said. 
Protected time for NHS staff when they do trials 
is also important. You cannot ask a workforce that 
stands with its back to the wall to trial new things; 
the outcome will not be good. Nobody would do 
that.  
Alex Matthews: In almost every instance, the 
technology that we need to deliver excellent health 
and social care in Scotland exists. Therefore, the 
challenge is to establish the right conditions to put 
it in place. That covers a lot of what we have 
discussed. It is about making sure that there is 
sufficient clinician and patient involvement in 
developing and deploying technology, strong top-
down and, at times, directed leadership on how 
the technology should be deployed consistently 
across the system, and sufficient investment in 
business change to make deployment successful 
on the ground. We need to embrace modern 
technologies and the methods for deploying them, 
and we need to be proportionate about how we 
apply governance to the projects and programmes 
that are charged with bringing in technology. 
A wider observation is that I am always 
concerned about talk of establishing a single place 
for innovation within an organisation or system, as 
that can prevent innovation from happening 
elsewhere. 
The Convener: I thank everyone for a very 
interesting discussion. Many of the points that you 
have raised will give us food for thought as we 
take this issue forward. If you have any more 
information for the committee, please do provide it 
subsequently. 
The meeting will now go into private session. 
12:36 
Meeting continued in private until 12:53. 
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